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Antipsychotic medication is the predominant intervention used for psychosis in the 
UK. However, there are risks associated, it is not always effective and service-users 
express ambivalence towards taking it. The research aims to explore community 
mental health professionals’ perspectives on working with people with psychosis 
who express antipsychotic ‘medication refusal’. 
 
Method 
A mixed-methodology was utilised. A survey of community mental health 
professionals was undertaken (N=74) to enquire about frequency of medication 
refusal and actions taken by professionals. Four uni-professional focus-groups were 
held to discuss the topic. The resulting data was subjected to a discursive analysis. 
 
Findings 
Antipsychotic medication refusal was presented as a common experience by 
participants, with service-users often stopping against advice. A substantial 
proportion of survey participants reported experience of supporting service-users 
without using antipsychotics or to come off, with good rates of success. ‘Risk talk’ 
was a prevalent feature of the focus-groups: a range of ‘risk’ repertoires were drawn 
on by participants to warrant particular actions.  
 
Implications 
Government initiatives relating to service-user choice, empowerment and recovery 
in mental health are in opposition to more pervasive ‘risk’ discourses. The notion of 
‘risk’ in relation to antipsychotics needs further consideration, with professionals 
made more aware of its social construction and alternative conceptualisations of 
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Antipsychotic medication is the primary intervention recommended for psychosis-
related diagnoses in the UK [National Institute for Health and Clinical Excellence 
(NICE) 2009]. Although service-users often report finding medication helpful, there 
are associated difficulties and the potential for harmful effects are well known 
(Gardner, Baldessarini and Waraich, 2005). Service-users frequently do not take 
medication as prescribed, can discontinue taking it against medical advice, and are 
often dissatisfied with professionals’ responses when requests for support with 
coming off are made (Read, 2005).  This research aims to explore community mental 
health professionals’ perspectives on working with people with psychotic 
experiences who express that they do not wish to take or wish to come off 
antipsychotic medication. In order to save space, I will summarise this notion as 
‘medication refusal’1.  
 
1.2. PLAN 
May (2001) argues for a more reflective approach in psychology, as the objectivity 
usually promoted can create a distance between the professional and their 
experience. In acknowledging the influence I bring to the research, I will write in the 
first person. I will provide an account of how I came to this research, my position in 
relation to the research topic and theoretical assumptions underpinning my 
approach. I will move on to provide definitions and background information on 
antipsychotics before setting out competing accounts surrounding the utility of 
antipsychotic medication. I will move on to explore the notion of ‘compliance’ to and 
discontinuation of antipsychotics. I will end by exploring some of the contextual 
factors surrounding decision-making about medication before outlining the rationale 
for the research2. 
     
                                            
1 A negative connotation is not implied  





There are several strands which have brought me to this topic. As a child I had 
limited exposure to my grandmother’s occasional mental health ‘breakdowns’, 
diagnosed as ‘manic depression’: they were concealed behind closed hospital doors, 
but I remained curious. My curiosities led me onto a path into clinical psychology. As 
my career has progressed, influenced by critical literature (e.g. Smail, 2005; Bentall, 
2004), my scepticism about pathological accounts of ‘mental illness’ has grown. 
More recently, hearing service-user accounts at a conference of abominable 
treatment from mental health services, further encouraged me to undertake some 
critically-informed research.  A further influence was hearing my partner (a 
community mental health nurse) talk about his frustrations in working with service-
users who stop taking medication and the lack of other options available.  
 
I began to explore the literature on medication-free approaches and encountered 
Mind’s research exploring service-users experiences of coming off medication, which 
was critical of medical professionals’ responses (Read, 2005). I began to wonder 
about this issue from the perspective of mental health professionals, which led me to 
conceive of this as a potential idea for my doctoral research.  
 
No research is value free, even if it claims to be so (Fox & Prilleltensky, 1997). In the 
interests of reflexivity (Yardley, 1997) I will explicitly state my position in relation to 
the topic. I am sceptical of biomedical models of mental health and consequently 
about the purported benefits of chemical solutions. I believe that there should be 
choice in the interventions people in distress are offered. I believe that the focus in 
mental health should be broadened beyond the individual to wider contextual 
factors including family, institutions, and wider societal issues of inequality. The 
reader should note my position and what I bring as a researcher as they judge the 




1.4. THEORETICAL ASSUMPTIONS 
1.4.1. Social Constructionism 
The research is positioned within a social constructionist framework. Social 
constructionism has developed as a critical alternative to traditional psychology. It is 
a broad school and includes individuals taking a variety of positions on reality, 
personhood, language, personal agency et cetera (Burr, 2003; Parker, 1998). Burr 
(2003) has detailed common assumptions which underlie a social constructionist 
approach: a critical position towards taken-for-granted knowledge about the world; 
viewing assumptions about the world as historically and culturally specific; viewing 
knowledge as being constructed and sustained by social processes (i.e. interactions 
between people); and the view that different constructions of the world sustain or 
exclude particular social actions.  
 
1.4.2. Critical Realism 
Radical social constructionists take a relativist view of the world: a “truth” is always 
relative to a discursive or cultural frame of reference. This position is open to 
criticism that moral relativism can ensue with no rationale to advocate one 
construction over another (Burr, 2003). Willig (1998) has commented on the 
tendency of social constructionist researchers to absent themselves from making 
recommendations for improvement to practice, for fear of reifying particular 
constructions. She argues that the absence of taking a position can act to support 
oppressive constructions: inaction is an action. She takes an overt political position in 
her work, but notes that analysis should be reflexive and historically sensitive. She 
situates herself within a critical realism frame. A critical realist position might also be 
situated within social constructionism (Burr, 2003), but proposes that there are 
structures (i.e. biochemical, social structural, economic et cetera) underlying 
observable phenomena; these can never be directly accessed only known through 
their effects (Willig, 1998): what is true is not the same as what is held to be true 
(Collier, 1998). Constructions of the world are based on the underlying structures 




1.4.3. My position 
I would orientate myself closer to the critical realist position. Firstly, this arises from 
the topic in question: medication has real physical effects on people. However, these 
can be constructed in different ways and there are diverse discourses surrounding 
medication and practice, which have different effects (Harper, 1999a).  Secondly, this 
is applied research: I work within a real health service which exerts influence on 
practice and consequently the lives of service-users by virtue of the assumptions 
made about the world inherent in it. I would see that the key purpose of research is 
to lead to ‘improvements’ in practice and the experiences of service-users. This will 
ultimately involve advocating for some constructions over others.      
 
1.5. REVIEWING LITERATURE 
Given the breadth of literature surrounding psychosis and medication, a full 
literature review of the field is not feasible within the constraints of this thesis. I will 
give priority to research which has sought to empirically examine stakeholders’ 
perspectives in relation to the topic of enquiry, which will exemplify the different 
available constructions of the issue. I will also address competing accounts from the 
professional literature, alongside some examination of the service-context within the 
NHS. My aim is to present sufficient literature to establish a robust rationale for 
undertaking the research and provide enough context for the reader to understand 
and evaluate the research. 
 
1.6. ‘PSYCHOSIS’ 
For Bentall (2004) ‘psychosis’ refers to ‘madness’ or severe psychiatric disorders in 
which an individual appears to lose touch with reality. ‘Psychotic’ experiences refer 
to unusual perceptive experiences, for example voice-hearing in the absence of an 
external stimulus (‘auditory hallucinations’ in medical terms) and unusual or 
‘paranoid’ beliefs held by an individual but not shared by others in their social 
environment (‘delusions’ in medical terms) [The British Psychological Society (BPS), 
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2000]. The ICD-10 Classification of Mental and Behavioural Disorders (ICD-10; World 
Health Organisation, 1992, p2-3), defines “psychotic” as: 
..the presence of hallucinations, delusions, or a  limited number of severe abnormalities of 
behaviour,  such as gross excitement and overactivity, marked psychomotor retardation, and 
catatonic behaviour.  
 
The medicalisation of ‘madness’ in the nineteenth century sought to establish the 
biological origins of mental distress and establish it as the jurisdiction of doctors 
(Pilgrim and Rogers 1999). This construction is still dominant: psychotic experiences 
are conventionally seen as ‘symptoms’ of underlying ‘mental illness’, listed as items 
on psychiatric diagnostic criteria for a range of ‘mental disorders’, the most common 
of which is ‘schizophrenia’. The ICD-10 describes nine sub-types of schizophrenia and 
eighteen related disorders. Psychosis also features within several other categories of 
disorders outside of schizophrenia and its related “disorders”, including “disorders 
due to psychoactive substance use” and “mood disorders”.  
 
The validity, reliability and utility of ‘schizophrenia’ has been critiqued in detail by 
many authors, including in the last decade Boyle (2002) and Bentall (2004) and there 
are a range of alternative, but subjugated constructions of psychosis available. Boyle 
and Bentall suggest that the investigation of ‘psychosis’ should be done outside of 
the outdated and unscientific concept of ‘schizophrenia’. This is also advocated by 
the BPS Division of Clinical Psychology (BPS3, 2000). As such, I will refer to ‘psychosis’, 
rather than diagnostic labels, (unless these were used by particular literature 
referred to). 
 
                                            
3
 This is unsurprising given that Boyle and Bentall were contributory authors. 
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1.7. ‘ANTIPSYCHOTIC’ MEDICATION 
1.7.1. Background 
The use of antipsychotics in ‘treating’ psychosis is so prevalent that researchers 
report difficulties attempting to conduct research with drug-naïve patients (Bentall, 
2009). NICE (2009) guidance is that antipsychotics should be “offered” to people 
newly diagnosed with “schizophrenia”, “schizoaffective disorder”, “schizophreniform 
disorder” and “delusional disorder”, during acute episodes of the “disorder” and for 
one to two years after to prevent relapse (NICE, 2009). Bentall (2009) suggests that 
in practice, many people with psychosis are told that they should continue 
medication indefinitely to prevent ‘relapse’: known as maintenance treatment.    
 
1.7.1.1. Definitions 
Chlorpromazine was the first ‘antipsychotic’ drug to be introduced in the 1950s. First 
known as “major tranquillisers” and “neuroleptics”4 they were only later referred to 
as ‘antipsychotics’ (Moncrieff, 2008). The current British National Formulatory5 (BNF-
58; British Medical Association and the Royal Pharmaceutical Society of Great Britain, 
2009) lists 23 oral and 6 depot6 preparations of antipsychotic drug. They are 
recommended for the relief of “florid psychotic symptoms”, to “prevent relapse” in 
“schizophrenia” and as tranquillisers:  
 
…to calm disturbed patients whatever the underlying psychopathology, which may be 
schizophrenia, brain damage, mania, toxic delirium, or agitated depression. (p 194). 
 
                                            
4
 Meaning nerve-seizing; a name which is preferred and argued by some authors to be more accurate descriptions of their 
mode of action (Moncrieff, 2008; Breggin, 1993) 
5 The British National Formulatory is a reference book for prescribers, pharmacists and professionals which is published 
biannually and purports to provide evidence-based up-to-date information on the selection, prescribing, dispensing and 
administration of all medicines available under the NHS. 
6 'Depot' preparations of antipsychotics are long-acting form of the medication administered via an intra-muscular injection in 
the buttocks, often as an out-patient, by a Community Psychiatric Nurse. Some authors have alluded to the potential for this to 
be a humiliating experience for service-users (Day and Bentall, 1996).  
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1.7.1.2. Mode of Operation 
 Antipsychotics are purported to alleviate the ‘symptoms’ of psychosis through 
blocking dopamine D2 receptors (BNF-58, 2009). This thesis has led to the enduring 
and often reformulated (tautological) hypothesis that “schizophrenia” (or more 
recently only the ‘positive’ psychotic symptoms of schizophrenia) is caused by 
abnormalities of dopamine in the brain, which antipsychotics operate to reverse 
(Howes & Kapur, 2009): a theory that has filtered into common psychiatric discourse 
so that psychiatric drugs such as antipsychotics are often promoted by health 
professionals as correcting a “chemical imbalance” (Double, 2005; Moncrief, 2008). 
This argument has been challenged. Johnstone (2000) suggests it is a form of 
“backward logic” akin to suggesting that headaches are caused by a lack of aspirin. 
Furthermore, the mode of operation on ‘symptoms’ of the various antipsychotic 
drugs is less than clear, for example all antipsychotics act on multiple 
neurotransmitters in addition to dopamine and not all bond potently to D2 receptors 
(Miyamoto, Duncan, Marx and Lieberman, 2005). Certain antipsychotics in particular 
are “dirty” drugs which act at multiple receptors (Healy, 2005). In a review of modern 
antipsychotic drugs, Gardner et al. (2005) argue that  
“pharmacocentric and circular speculations about altered dopaminergic function, have not 
led to a better understanding of the pathophysiology or causes of the several still 
idiopathic psychotic disorders, nor have they provided a non-empirical, theoretical basis 
for the design or discovery of improved treatments for psychotic disorders.” 
 
1.7.1.3. ‘Side Effects’7 
The original antipsychotics of the 1950s (e.g. chlorpromazine and haloperidol) were 
associated with severe and undesirable neurological effects, associated with their 
action on dopamine receptors, known as extrapyramidal side-effects; referring to 
changes in voluntary movement (Gardner, Baldessarini and Waraich, 2005).  
Arguably the most serious extrapyramidal side-effect, due to its lasting nature 
following discontinuation of medication, is tardive dyskinesia, which chacteristically 
involves spasmodic movements of the jaw and tongue.  
                                            
7




Other ‘side-effects’ include endocrine and metabolic effects, such as weight gain, 
hyperlipidemia and hyperglycaemia leading to diabetes; elevated prolactin levels 
leading to changes in sexual functioning, lactation and breast swelling;  and 
cardiovascular effects, such as raised blood pressure, tachycardia, stroke and sudden 
cardiac death (Gardner et al., 2005).  
    
1.7.1.4. ‘Second Generation’ Drugs 
Demand for drugs with better “side-effect profiles” led to the re-launch of Clozapine 
in the late 1980s; an ‘atypical’ antipsychotic, in that it did not seem to produce 
extrapyramidal side-effects (Gardner et al., 2005).  It was also claimed to produce 
improvements in a significant proportion individuals who had been unresponsive to 
conventional antipsychotics (Kane & Meltzer, 1988). Clozapine had previously been 
found, however, to cause potentially fatal agranulocytosis8 and was re-launched only 
for use with individuals with “treatment resistant schizophrenia” who had not 
responded to other drugs, with close monitoring and regular blood testing required. 
 
Following the reintroduction of Clozapine, further ‘atypical’ antipsychotics were 
launched in the 1990s including Olanzapine, Resperidone and Amisulpiride 
(Miyamoto et al, 2005). They were initially claimed to have similar benefits to 
Clozapine in terms of efficacy and side-effect profiles but without the risks (Healy, 
2005). The terms ‘typical’ and ‘atypical’ antipsychotic have been superseded in most 
literature by “first-generation” and “second-generation” antipsychotics, due to the 
recognition that the so-called ‘atypical’ antipsychotics do not constitute a 
homogenous class of drugs, have diverse pharmacological actions and most still have 
the propensity to cause extrapyramidal side-effects; certain of the newer drugs also 
have a greater propensity for producing metabolic abnormalities (NICE, 2009; 
Gardner et al., 2005).  Although the first NICE guidance on the treatment of 
schizophrenia recommended that an ‘atypical’ antipsychotic be prescribed as the 
                                            
8 An acute condition involving severe and dangerous lowered white blood cell count. 
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first line of treatment in newly presenting cases of schizophrenia (NICE, 2003), the 
most recent guidance (NICE 2009) does not recommend second-generation above 
first-generation drugs: the drug should be chosen depending on what seems most 
appropriate for the individual.  
  
1.7.2. Accounts of Utility 
In this section a range of accounts about the utility of antipsychotics will be 
presented, drawing on the professional literature and research examining service-
user perspectives. 
 
1.7.2.1. Professional Literature 
Bentall (2009, p220) states that there is “no doubt” about the short-term benefits of 
antipsychotics in producing quick relief from psychotic symptoms. However, not 
everyone with psychosis is considered to “respond” in a therapeutic way. Bentall 
states that the proportion of “non-responders” is difficult to estimate, but draws on 
Kane (1989) to suggest rates of between a quarter and a third of individuals. 
 
When chlorpromazine was first synthesised by Laborit in the 1950s, it was its 
propensity to induce a state of “disinterest” in one’s surroundings which led to it 
being trialled on psychotic patients and subsequently being found to have useful 
effects for this patient-group (Mckenna, 2007). Subsequent claims were made that 
these drugs work by having specific effects on the underlying pathology of 
schizophrenia and psychosis. Mckenna (2007) cites a National Institute of Mental 
Health study (1964) as providing evidence that antipsychotics have selective effects 
on the symptomology of schizophrenia, beyond purely sedation and tranquillisation. 
He points to findings that the improvement on symptoms such as hostility, 
aggression and anxiety were less than for symptoms such as delusions and 
hallucinations. Moncrief (2008) disputes that neuroleptics act specifically on the 
mechanisms underlying psychosis, which she terms a “disease-centred model”, she 
argues that other types of drugs (such as benzodiazepines) can produce similar 
17 
 
effects on psychotic symptoms, but have received little investigative effort. She 
proposes a “drug-centred model”, which views psychotropic drugs as inducing 
particular psychological states which must be judged for their usefulness and 
balanced against adverse effects.  
  
Healy (2005) provides a similar argument. He disputes that antipsychotics are 
“antischizophrenic”: like coffee or alcohol they tend to have similar effects on 
anyone taking them. He argues that the effect they have is to produce a feeling of 
detachment or a “who cares” feeling, which is why they appear to get rid of 
psychotic symptoms such as voices and delusions. The voices or beliefs are usually 
still there, but the person is less bothered by them and able to concentrate on other 
things. In this sense he argues for their utility at appropriate doses and places the 
patient’s subjective experience of the helpfulness of the drug at the centre of the 
prescribing process.   
 
Breggin (1993) is more scathing of antipsychotics, citing them as “the most 
dangerous medications ever used in medicine” (p.108). He argues that so called 
“antipsychotic” drugs act as “chemical lobotomies” which do not provide specific 
treatment for particular symptoms, but rather act to generally blunt and subdue 
individuals and reinforce the patient’s role as the “helpless sick person”. He argues 
that both antipsychotics and psycho-surgery act on the brain dopaminergic pathways 
leading to the frontal lobes and limbic system. Antipsychotics are thus argued to 
produce their desired effect by impairing normal brain functioning. He cites research 
which suggests that for a significant proportion of individuals these impairments are 
permanent. Similarly, Healy (2005, p256-257) suggests that professionals and 
service-users need to be aware of the potential for permanent changes in brain 
systems following treatment with antipsychotics. He suggests that “the act of 
therapy changes people forever….starting and stopping treatment is not the same as 
not starting.” A recent review of the research on the impact of antipsychotics on 
brain structure concludes that antipsychotics have the potential to produce 
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structural changes in the brain, but methodological flaws and inconsistencies mean 
that research findings have yet to produce a clear picture (Navari and Dazzan, 2009).    
 
Antipsychotics and other physical treatments are widely heralded as having enabled 
the de-institutionalisation of the 1960s and subsequent establishment of community 
psychiatric care. Black (2005) states that psychiatric hospitals were emptied following 
the discoveries of ECT, Lithium and Chlorpromazine. Other researchers question this 
version of history. Johnstone (2000) agrees that the introduction of drugs such as 
neuroleptics and de-institutionalisation occurred at about the same time, but cites 
evidence to suggest that numbers of psychiatric inpatients had already started to fall. 
Healy (2005) suggests that it is difficult to disentangle the relative influences which 
led to community care, but suggests that the use of drugs engendered a willingness 
for more risks to be taken in discharging people. Harper (1999b) observes that 
outside of the hospital, diagnosis and medication serve to fix people in a conceptual 
and ideological space, as opposed to the physical separation in the asylums. He 
suggests that medication continues as a form of physical regulation through 
Dispensary Power which replaces the confinement and physical restraint of the past. 
 
1.7.2.2. Service User Perspectives 
Studies utilising a range of methods have been undertaken to investigate service-
users attitudes towards and experiences of taking antipsychotics, which I will detail 
in this section.  
 
Rogers and Pilgrim (1993) surveyed service-users’ views of taking antipsychotics, 57% 
reported finding them helpful; 62% reported that side-effects had been severe or 
very severe. They note that qualitative data suggested substantial levels of 
ambivalent and negative attitudes towards the drugs, which was not necessarily 
reflected in overall quantitative ratings. They conclude that on-the-whole service-
users are critical of these drugs. Similarly, Day, Bentall and Warner (1996) found that 
service-users have complex relationships with medication which are not simply pro 
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or anti. They conceptualised four types of “subjective attitudes” towards 
antipsychotics:  
1) “unquestioning, uncomplaining, dependent”: expressed dependence on 
drugs and strong belief in the authority of the doctor; 
2) “autonomous, sceptical”: expressed a negative attitude towards drugs and a 
concern for being autonomous;  
3) “balanced appraisal”: concerned about side-effects, but acknowledging the 
benefits of medication; 
4) “autonomous responding”: medication seen as beneficial, but did not express 
dependence on it.      
They suggest that clinicians being sensitive to service-users’ attitudes towards 
medication would have a positive impact on the therapeutic alliance, which in turn 
can improve outcomes. 
 
Rogers, Day, Williams, Randall, Wood, Healy, and Bentall (1998) undertook a detailed 
exploration of the meanings service-users attach to medication, interviewing 34 
service-users on long-term regimes of antipsychotics. They present qualitative 
findings, exemplifying their claims with extracts from the interviews but the method 
of qualitative analysis is not described. There were a range of reported costs and 
benefits associated with taking antipsychotics. Benefits included “calming” effects, 
control of specific symptoms such as voices or unwanted thoughts and as an aid to 
coping with particular situations. Problems included side-effects and the impact that 
these had on participants’ abilities to engage in daily activities. Side-effects most 
frequently reported included “drowsiness, tiredness, sleepiness”, followed by 
restlessness and lack of motivation. Some participants reported that there was little 
to choose between the undesirable effects of the medication and psychotic 
symptoms. The authors suggest that participants had developed knowledge of how 
much medication they needed and would vary it themselves by raising or lowering 
the dosage in particular circumstances. Participants did not see antipsychotic 
medication as being akin to medication taken for other conditions, because of the 
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potential sanctions for not taking it. Participants were aware of mental health 
legislation and expressed a fear of coercive treatment if they did not take their 
medication. Some participants reported being persuaded to take their medication by 
mental health professionals in the community. There was also expression of the 
stigma associated with mental health problems and the authors describe that 
participants perceived a “social contract” whereby taking medication enabled them 
to live in the community. Similar recommendations are made to those emerging 
from the Day et al., study: professionals should acknowledge service-users own 
definitions of their situation and self-management strategies, with the goal of 
working collaboratively together. They suggest that future research might be 
invested in rethinking the nature of patient/professional encounters around 
medication  
 
Carrick, Mitchell, Powell and Lloyd (2004) undertook a qualitative study of the 
experience of taking antipsychotics, using grounded theory. A core category of 
“maximising Well-being” emerged. Well-being was defined in terms of normality of 
feeling, function and appearance. A struggle was presented in trying to reduce both 
side-effects and illness symptoms which were both seen as detracting from “well-
being”. Medication was viewed in terms of “sufferance” to be “put up with” for 
sufficient benefits. Clear views were expressed as to whether medication was “worth 
it” overall, which differed from person to person. More than 60 side-effects were 
mentioned and in common with Rogers et al.’s findings, tiredness was most 
common, but was reported to not be taken seriously by doctors. As in Rogers et al.’s 
study, there was a concern that hospitalisation was a likely consequence of non-
adherence and that choices were limited. Recommendations similar to those 
detailed in the other studies are made: in order to achieve a cooperative partnership, 
doctors need to clarify service-user goals. Service-users are argued to be best-placed 






This section has examined accounts of the utility of antipsychotics. We can see from 
the varying accounts presented here, that this is a contested topic amongst both 
professionals and service-users. Antipsychotics are not useful in a straightforward 
way and there are many levels of complexity. Research looking at service-user 
perspectives recommends that professionals take steps to acknowledge the 
uniqueness of service-user positions and that service-users have expertise in judging 
and managing their own medication-related behaviour.  
 
1.8. MEDICATION ‘COMPLIANCE’ 
1.8.1. Why medication is deemed necessary 
Service-user adherence to antipsychotics as prescribed is usually presented as being 
essential to maximise therapeutic outcomes in individuals diagnosed with 
schizophrenia (Velligan, Lam, Glahn, Barrett, Maples, Ereshefsky and Miller, 2006) 
with non-adherence and medication discontinuation presented as significant 
“management” issues (Awad, 2004) and as predictive of “relapse” (e.g. Robinson, 
Woerner, Alvir, Bilder, Goldman, Geisler, Koreen, Sheitman, Chakos, Mayerhoff, and 
Lieberman, 1999). As we have already seen, service-users do not find medication 
straightforwardly beneficial and outcome-measures from some medication trials 
support this. For instance the Northwick Park Functional Psychosis  Study found that 
although “maintenance treatment” with antipsychotics reduced the risk of “relapse” 
compared to those treated with a placebo, there were better occupational outcomes 
for participants in the placebo group (Johnstone and Geddes, 1994). 
  
From a sociological perspective, Pilgrim and Rogers (1999) comment that psychiatric 
patients’ non-compliance with medication is seen as a significant social problem, tied 
up with ensuring the success of community care. They suggest that the media has 
depicted medication as a valid means of managing and controlling people viewed as 
a threat to the social order. The need for compliance stems not only from public 
pressure but is a key component of the management of mental health problems. 
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These observations have been borne out with the recent addition of Community 
Treatment Orders (CTOs) to mental health legislation (Mental Health Act, 2007, Ch. 
4). Such orders can compel individuals with “mental disorder” who have previously 
had a hospital admission to comply with medical treatment in the community, with 
consequent recall to hospital if the terms of the order are not met. The rationale 
being “to prevent risk of harm to the patient or others”.  
  
1.8.2. Language 
In contrast with increasingly restrictive mental health legislation, the discourse in the 
professional literature has moved from “compliance”, implying service-user passivity 
and obedience to the practitioner; to “adherence”, argued to infer a collaborative 
relationship between the service-user and practitioner (Singh et al., 2006) and 
“concordance”, defined as the degree to which clinical advice and health behaviour 
agree (Mitchell & Selmes, 2007). Recent NICE guidance (“Medicines adherence”, 
2009) uses the term “adherence”, defined as: 
“ ….an agreement between prescriber and patient about the prescriber’s 
recommendations…the extent to which the patient’s action matches the 
agreed recommendations.” (p. 4)  
    
Day and Bentall (1996) are sceptical about whether simple changes in terminology 
can address the problem of “paternalism” inherent in the notion of “compliance”.  
 
A distinction is made in recent adherence literature between unintentional (e.g. 
misunderstanding instructions or forgetting) and intentional non-adherence 
(deciding not to follow recommendations) (NICE, 2009). “Intentional non-adherence” 
is further divided into “medication refusers”, “irregular compliance” and “medication 
discontinuation” against recommendation (Velligan et al., 2006; Mitchell & Selmes, 
2007).  It is suggested that the majority of individuals diagnosed with schizophrenia 
would fall into the “irregular” category, but there has been little research on overt 
medication refusal (Mitchell & Selmes, 2007). In relation to medication 
discontinuation, several large scale trials have found particularly high rates of 
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medication discontinuation: the Clinical Antipsychotic Trials of Intervention 
Effectiveness (CATIE), which compared first and second generation antipsychotics, 
found that 74% of participants discontinued the study medication before 18 months 
(Swartz, Stroup, McEvoy, Davis, Rosenheck, Keefe, Hsiao, Lieberman, 2008).    
 
1.8.3. Adherence to antipsychotics 
Given the importance placed on antipsychotics as a ‘treatment’, much effort has 
been invested in examining the reasons for non-adherence, in order that rates might 
be improved. As such, there is an a priori assumption in most “adherence” literature 
that non-adherence is a negative thing to be reduced.  
 
Reviews of the literature relating to antipsychotic medication adherence 
acknowledge that there has been little agreement regarding how adherence is 
operationally defined and best measured (Velligan et al., 2006). This variability has 
led quoted rates of non-adherance in individuals diagnosed with schizophrenia to 
range from 20% to 89% with an average of 50%; depot medication is often 
recommended as a solution (Singh, Massey, Thompson, Rappa and Honeywell, 2006).  
Adherence to prescribed medications is not only an issue for psychiatry: the NICE 
guidance relates to the prescribing of medication generally. NICE suggest that 
between a third and half of all medicines prescribed for long-term conditions are not 
taken as recommended.   
 
A recent UK national household survey has examined adherence to psychiatric 
medication using structured interviews (Cooper, Bebbington, King, Brugha, Meltzer, 
Bhugra and Jenkins, 2007). Overall, 34% of those prescribed a psychiatric drug 
reported that they were not fully adherent. The rates of self-reported non-adherence 
in individuals diagnosed with psychosis were not significantly different from those 
taking other types of psychiatric medication. For those taking antipsychotics, side-
effects were more commonly cited as reasons for not adhering than for other 
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medications. Across the whole sample, not wanting to take medications or not 
thinking they were needed were major reasons given for non-adherence.    
 
1.8.4. Discourses of “compliance” 
David Harper (1999b) explored the discourses surrounding medication in a chapter of 
his PhD thesis. His research involved individual interviews with service-users and the 
psychiatrists, GPs and nurses involved in their care. The interviews were subjected to 
discursive analysis alongside an analysis of wider literature. Harper identified two 
opposing discourses as being available in relation to non-compliance: Non-
compliance as not following medical advice and Non-compliance as an assertion of 
agency and choice.  
 
Within the first discourse, he argues that failure to take medication is constructed by 
professionals as being an effect of the illness (in terms of ‘insight’) and as morally 
irresponsible. Compliance is seen as inherent in the service-user as apposed to the 
doctor-patient relationship, and is seen in either/or terms, rather than as on a 
continuum. The result is that the responsibility for ‘compliance’ is located with the 
service-user.  
 
In the second discourse, prescription regimes are seen as a result of negotiation or a 
power struggle between the doctor and service-user which may be constructed in 
terms of: defiance of medical authority, a breakdown in the doctor/service-user 
relationship, a self-protective response, a valid decision or as self-medication. Within 
this discourse, responsibility for non-adherence is located in the doctor-patient 
relationship or the doctor’s actions, and negotiation is warranted. Withdrawal of 
service-user cooperation is warranted if such negotiations are unsatisfactory. This 
might be expressed through the service-user reducing their dose or refusing to take 
medication. Within this discourse, service-user expertise and rights are valued and 
they are able to assert agency through making decisions about their medication 
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regime. The research discussed in the next section might be seen in terms of the 
second discourse.  
 
1.8.5. Coming off Medication 
As we have seen in the studies detailed in Section 1.7.2.2, service-users provide 
sophisticated accounts as to the costs and benefits of medication and some take the 
decision to stop taking it. 
 
1.8.5.1. Mind’s research (Read, 2005) 
The mental health charity Mind conducted research with 204 individuals who had 
attempted to come off a variety of psychiatric medications. Participants were 
interviewed using a structured questionnaire, with a smaller sample partaking in in-
depth interviews. Twenty one of the sample had tried to come off antipsychotics. 
The most common reason given for deciding to come off medication was adverse 
effects (60%) followed by not wanting to take medications long term (53%) and 
feeling things were better so medication no longer needed (37%). Of the 21 
participants in the study who had been taking antipsychotic medication, over 60% 
tried to come off their drugs either against medical advice or without informing their 
doctor. The reason given for not telling the doctor was usually because of fear of 
opposition or compulsion. The study participants rated psychiatrists and GPs as being 
the least helpful people in terms of offering support with coming off medication 
(particularly by those who wanted to come off antipsychotics) and 
counsellors/psychotherapists as being most helpful. The results suggested that there 
are not clear rules predicting likelihood of success and that doctors are not good at 
predicting who is able to safely come off.  
 
The authors encourage more debate of the issues between interested parties; call for 
further research to be undertaken around withdrawal from psychiatric drugs; and 
suggest training for professionals on understanding service-users perspective on 
psychiatric drugs. Limitations of the research include the small sample size, 
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particularly in relation to antipsychotics, the lack of ‘scientific’ peer-review (although 
the results have been presented and discussed in public forums) and insufficient 
detail in the report about the analyses undertaken. However, the research raises 
important questions for the role of professionals in working with this issue. 
 
1.8.5.2. Advice on “Coming off” 
David Holmes is a clinical psychologist working in a Community Mental Health Team 
(CMHT) who has written in professional and service-user literature about coming off 
antipsychotics. He notes that there is little help available for people who want to try 
to come off medication and has written a list of “top tips” for coming off based on his 
clinical experience (Holmes & Hudson, 2003).  
 
Writing in a clinical psychology professional practice journal after encountering 
Mind’s research on “coming off” Holmes (2006) expresses curiosity as to how 
psychologists respond to people talking about medication and expressing that they 
want to stop taking it. He suggests that psychologists might be useful professionals 
for service-users to talk to about this issue and outlines the way he works with 
service-users who raise medication issues. For service-users who express curiosity in 
coming off, he recommends a structured joint brainstorming exercise where the pros 
and cons of continuing or coming off medication are explored. He also recommends 
books to service-users to read to help inform their decision. He suggests that the 
written result of the brain-storming exercise can be shared by the service-user with 
family or other professionals involved in their care, which can promote a climate of 
collaboration. Holmes suggests that although coming off medication can be a ‘risk’, 
so are other potentially helpful or stressful things in life. He concludes with a call to 
psychologists to use their relatively powerful positions to advocate for people who 




1.8.6. Minimal/Non Medication Approaches 
There is a small body of research which has explored minimal or non-medication 
approaches to working with psychosis. Bola (2006) notes the limited number of good 
quality studies which have allowed comparison between initial treatment of first-
episode schizophrenia with and without medication. In his review of the literature, 
he identified seven studies with sufficient methodological robustness, where a 
medicated group was compared with a non-medicated group (including drug 
placebo, therapeutic mileau, and psychotherapy). Only four of these involved 
random assignment to groups. Calculation of effect sizes showed no advantage for 
early treatment with antipsychotics over non-medication approaches. Calton, 
Ferriter, Huband, and Spandler (2008) undertook a systematic review of the 
published literature on the “Soteria Paradigm”: a therapeutic community alternative 
to hospitalization, for those diagnosed with schizophrenia. The authors define the 
core principles of this approach as: 
 
the provision of a small, community-based therapeutic milieu with significant lay person 
staffing, preservation of personal power, social networks, and communal responsibilities, a 
‘‘phenomenological’’ relational style which aims to give meaning to the person’s subjective 
experience of psychosis by developing an understanding of it by ‘‘being with’’ and ‘‘doing 
with’’ the clients, and no or low-dose antipsychotic medication (with all psychotropic 
medications being taken from a position of choice and without coercion).  
 
They found that the outcomes of this paradigm were comparable with standard 
treatment,   therefore no disadvantage was incurred by the lack of antipsychotic 
treatment. In a further article, Carlton & Spandler (2009) discuss a range of other 
minimal-medication approaches. These include, a psychosocial approach developed 
in Finland, the outcomes of which were that for the experimental group (psycho-
social, minimal-medication approach): 43% had never taken medication (compared 
to 6% of the standard treatment group), there was significantly less hospitalization 
and fewer psychotic symptoms. They conclude by calling for greater consideration of 




The findings from the research described here serves to challenge the conventional 
assumption that compliance with antipsychotic medication is always necessary. 
 
1.8.7. Summary 
This section has explored issues around the notion of medication ‘compliance’. The 
mainstream of psychiatry, convinced of the necessity for continued antipsychotic 
treatment, direct research towards improving rates of compliance. However, there 
are alternative discourses centred on choice, with a minority of bodies and 
professionals advocating for supporting service-users to come off medication and 
minimal-medication approaches.    
 
1.9. MAKING DECISIONS ABOUT MEDICATION 
This section will further explore some of the issues and contexts surrounding 
decision-making about antipsychotic medication, including: the legal framework, 
government agendas and the context of medical consultations. 
  
1.9.1. Choice,  Consent & Recovery 
1.9.1.1. Informed Consent 
The notion of informed consent to treatment has become a central issue in medical 
ethics and there are particular issues in relation to mental health. According to Davis 
(2009), consent must be obtained in order for a treatment to be given lawfully and 
can only be meaningful if a full explanation of the treatment has been given: an 
individual is able to refuse a treatment, without undue pressure being placed. 
However, legislation allows rights to be overridden in particular circumstances: 
where an individual is deemed to lack mental capacity9 to make the decision, in 
                                            
9 The Mental Capacity Act (2005) states that a person is unable to make a decision if he or she is unable to: understand the 
information relevant to the decision; retain the information for long enough to be able to make a decision; use or weigh up 
the information as part of the process of making the decision; communicate the decision by any possible method, such as 
talking, using sign language, squeezing someone’s hand and so on.  
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which case decisions are made by professionals in the best interests of the person, in 
consultation with the individual’s family and friends; and if an individual is detained 
under certain sections of the Mental Health Act (2007). However, legal powers must 
not be used as a threat to coerce an individual into consenting. 
 
Healy (2005) discusses the complexities around informed consent. He suggests that 
there are factors which can undermine the notion of voluntary consent to treatment, 
including: the pressures involved in medical consultations preventing full discussion 
of treatment options; the way in which treatment options are presented; the diverse 
views which different mental health professionals might provide on the nature or 
purpose of the treatment; and the reluctance by professionals to present the lack-of-
certainty about particular treatments. Carlton & Spandler (2009) contend that in 
order to give consent, individuals must be aware of the range of choices available 
and that often the only choice on offer is medication.   
 
1.9.1.2. Choice 
The notion of “consumer choice” has become increasingly prevalent within NHS 
government directives in the past ten years. The Department of Health white paper 
(DoH; 2006) Our health, our care, our say: a new direction for community services 
states the government’s plan to develop more personalised health and social care 
services which make information available to service users, provide greater choice 
about the help and support available and give service-users more power to influence 
the standards of local services. It stipulates the requirement for services to seek 
service-user views and involve them in decision-making.  
 
Research detailed in Sections 1.7.2.2 suggests that service-users often feel coerced 
into complying with medication regimes. Other research has investigated the extent 
to which service-users feel involved in decisions about being prescribed 
antipsychotics (e.g. Paton and Esop, 2005; National Schizophrenia Fellowship, 2000). 




The main findings being that a substantial proportion feel that they are not provided 
with sufficient information about the medication prescribed to them and are not 
involved with the decision-making about choice of drug.  
 
1.9.1.3. Recovery 
The notion of “recovery” in mental health has grown in recent years and is argued to 
have its roots in the USA in users’ personal stories of recovery from mental illness 
which challenge the idea that recovery from severe mental health problems is 
uncommon (Wallcaft, 2005). Some of the key ideas integral to the concept of 
recovery include forging new ways of living based on self-agency, self-help, hope, 
developing coping strategies and sharing these with others (Ramon, Healy and 
Renouf, 2007). These ideas might be seen to fit with Harper’s identified discourse: 
Non-compliance as an assertion of agency and choice.  
 
The DoH has utilised the concept of recovery in agendas for service provision, for 
instance: The Journey to Recovery– The Government’s vision for mental health care 
(DoH, 2001) argues that a positive and optimistic approach needs to be taken 
towards those who use mental health services which enables individuals to have 
access to resources which they believe are critical to their own recovery.  
 
1.9.2. Medical Consultations 
Seale, Chaplin, Lelliot and Quirk (2006) examined the discussion of antipsychotics in 
psychiatry outpatient appointments. This research is useful in highlighting some of 
the issues around decision-making in relation to antipsychotics. 
 
Qualitative interviews were held with 65% of consultant psychiatrists across two 
mental health trusts (N=21) on the topic of out-patient consultations involving 
antipsychotic discussion. The results were analysed using thematic content analysis. 
The psychiatrists positioned themselves as taking a “patient-centred” approach 
within consultations, through use of understandable language, greater provision of 
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information about treatment options, and more negotiation of decisions. They also 
expressed a preference for co-operative relationships, where decision-making was 
shared. This was reported to be achieved by listening to service-users views and 
experiences, showing empathy and understanding, being honest and being “human”. 
Most presented medication as being the most important treatment for people 
diagnosed with schizophrenia. Participants raised issues about the dilemmas 
involved in discussing the adverse effects of medication with service-users, in terms 
of how much information to provide and the impact this might have on compliance, 
own lack of knowledge, and fear of litigation. There were also reports of the use of 
manipulative strategies, such as bargaining, deception in the service-user’s “best 
interest”, and the use of persuasion. The participants described at times the need to 
take a more directive or coercive approach, particularly if service-users were thought 
to lack “insight” or be “very psychotic”.  
 
In discussing the findings, the authors observe that despite preferences for shared 
decision-making, the inherently asymmetrical nature of the relationship whereby the 
psychiatrist assesses the service-users’ competence to take decisions, can mitigate 
against this. The dilemma between sharing information with service-users and 
encouraging treatment might also undermine a commitment to shared-decision 
making. The authors recommend that further research be undertaken examining the 




In this section we have seen that apparently progressive policies relating to informed 
consent, choice, recovery and service-user involvement may be undermined at the 
point of service, when it comes to antipsychotic drug treatment, due to the 




1.10. RESEARCH RATIONALE 
We have seen that there are contested issues in the area of antipsychotic medication 
use and ‘refusal’. Research suggests that service-users want to have more choice in 
how and if they take antipsychotics and if this is not supported may stop without 
medical supervision. We have seen in research with psychiatrists that there are 
apparent dilemmas in working with conflicting agendas in mental health. 
Psychiatrists, in the main, are the only professional group prescribing antipsychotic 
medication10. However, given that mental health teams (in their various guises) in 
the community are multidisciplinary, mental health professionals of various 
disciplines work directly or indirectly with service-users taking antipsychotic drugs 
and many are expected to monitor medication as part of their role. It is unclear 
whether the same dilemmas might be present for mental health professionals from 
other disciplines, as to date little research effort has been directed at this. It might be 
expected that different disciplines draw on different frames of reference for working 
with such issues. This research aims to address questions of this nature.    
 
1.11. RESEARCH AIMS 
The research aims to explore antipsychotic ‘medication refusal’ from the perspective 
of community mental health professionals. There are two aspects to the research: 
 
a) An exploration of the accounts the professionals give of: 
 How often service-users express ‘medication refusal’ 
 What actions they take in response 
 How often they have supported service-users without medication or to 
come off medication  
 Confidence in working with these issues 
 The relative influence of different stake-holders in decision-making in 
relation to this issue 
 Availability of non- medical approaches 
                                            




b) Harper (2008) notes that in the field of mental health, discourse analysis has 
been useful in exploring contested issues. We have seen that antipsychotic 
medication is such an issue. As such a critical examination will be undertaken 
using a discursive framework of how professionals talk about these issues. This 
will pay attention to the accounts professionals give of their actions, the 







2.1.1. Theoretical Assumptions 
A social-constructionist approach does not advocate a particular research 
methodology: both qualitative and quantitative methods may be used (Burr, 2003). 
However, the assumptions underlying a social constructionist approach guide the 
kinds of questions asked and methods used to answer them. Consequently, 
particular methods have been more widely taken up than others: discursive 
approaches in particular (Section 2.1.3).  
 
Although guided by social constructionist assumptions, I have made methodological 
decisions based on pragmatic grounds. Within pragmatic approaches, the research 
question guides the choice of method, which is then judged on whether the purpose 
was met. This can lead to bespoke research designs combining different methods 
(Teddlie & Tashakkori, 2003).  
 
2.1.2. A Mixed Methods Approach 
As indicated in Section 1.11 I was interested to investigate the different accounts 
professionals give in relation to frequencies and actions taken around ‘medication 
refusal’, as well as how professionals talk about these issues and account for their 
actions. 
  
My interest in quantifying some of the issues (for example how frequently service-
users express medication refusal) was a result of being unable to find any existing 
research quantifying this phenomena from the perspective of professionals in the 
course of their day to day work, other than the “compliance” literature detailed in 
Section 1.8.3. It was also in part a ‘tactical’ consideration, acknowledged by Yardley 
(1997), in that numbers are often seen to provide stronger arguments and can be 
more influential on practice/policy (e.g. hierarchies of evidence used to construct 
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clinical guidance: DoH, 1999): Parker (2007) points to the use of opinion polls in 
emancipatory research in South America. My interest in how professionals talk about 
the issues and account for their actions in relation to ‘medication refusal’ stems 
more clearly from a social constructionist position in which the use of language to 
construct the world is examined. 
 
A two-pronged approach therefore is employed: 
a) A small-scale survey of professionals, through means of an online 
questionnaire, inviting professionals to give an account, in largely quantifying 
terms, in relation to antipsychotic ‘medication refusal’ (see Section 2.2.1.) 
b) A series of focus groups of professionals, which provided a more open forum 
for professionals to provide accounts on the topic of enquiry, to be analysed 
discursively (as detailed next). 
      
2.1.3. Using Discursive Methods 
In this section I will outline discursive methods of analysis and the approach I plan to 
utilise. 
 
2.1.3.1. Discourse Analysis 
A diverse range of activities are referred to as ‘Discourse Analysis’ (DA). The 
confusing and varied nature of the field is in part a product of analytic traditions 
developing in different academic disciplines (Hepburn & Potter, 2007). I will 
concentrate here on DA approaches which have developed within psychology.  
Discursive approaches in general question the assumption that language is merely 
neutrally descriptive of a “real” world. Discourse is seen as constructing reality and 
reality is collectively produced through social processes: discursive approaches study 
aspects of the constructive process and its products (Wetherell, 2001). The terms 




2.1.3.2. Discursive approaches in psychology 
2.1.3.2.1. Potter and Wetherell’s approach 
DA in psychology has its roots in a critique of traditional social psychology, originally 
articulated by Potter and Wetherell (1987). In this seminal text, Potter and Wetherell 
drew influence from linguistic philosophy, ethnomethodology, the sociology of 
science, semiotics and post-structuralist thought to propose a discursive approach 
which challenged assumptions at the heart of traditional psychology such as the 
notion of ‘attitudes’. For instance, they suggest that an ‘attitude’ is a discursive act in 
a specific context which serves a particular function rather than a stable internal 
state.  
 
They define discourse in an open way as “all forms of spoken interaction, formal and 
informal, and written texts of all kinds” which they contrast with a Foucauldian 
definition where discourse refers to “broader, historically developing linguistic 
practices” (p6-7).  (I will come back to this). Within their approach, discourses or 
texts are approached “in their own right” rather than, in the realist tradition, as a 
route to something beyond, such as cognition, attitudes or events. They view 
language as being both “constructed” and “constructive”: it is built from available 
resources (words, categories, common ideas, broader explanatory systems) and it 
builds versions of events and actions.  Variation in peoples’ accounting is to be 
expected, as talk is used for different purposes in different contexts e.g. blaming or 
justifying. DA aims to demonstrate the discursive processes involved in constructing 
the ‘world out there’. Potter and Wetherell use the notion of the interpretive 
repertoire to refer to what might be termed in other DA analytic traditions as a 
discourse. Interpretive repertoires are defined as: 
 
recurrently used systems of terms used for characterizing and evaluating actions, 
events and other phenomena……constituted through a limited range of terms 
used in particular stylistic and grammatical constructions. Often….organized 
around specific metaphors and figures of speech (tropes)…(p 149). 
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2.1.3.2.2. Discursive Psychology 
Edwards and Potter (1992) developed Potter and Wetherell’s original approach in a 
particular direction, which they called Discursive Psychology (DP). Under this rubric 
they initially undertook to further critique traditional fields of psychological research 
such as memory and attribution theories. Their concern is with the social action 
being done with talk: how are events described and explained? how are factual 
reports constructed? how are cognitive states attributed? They are also concerned 
with issues of stake: the way that peoples’ discourse is organised to resist actual or 
potential attempts to infer that they have particular interests. They draw on the idea 
of rhetoric as being a feature of everyday talk and suggest that rhetoric can be 
examined in order to identify the alternative arguments or versions of events which 
are being undermined. They outline nine rhetorical devices which are utilised by 










People in particular categories are expected to know 
certain things and the veracity of their account can be 
warranted by virtue of the category membership. 
Vivid description 
Used to create the impression of “perceptual re-
experience” or indicate that the speaker has particular 
observational skills. Can also be used to package 
contentious or problematic events.  
Narrative 
Related to vivid description. Can be used to increase 
the plausibility of an account. Offers an opportunity for 
fusing memory and attribution or event description 
and causal explanation.  
Systematic Vagueness 
Converse of vivid detail. Can provide a barrier to easy 
undermining whilst at the same time proving the 
foundation of an inference. 
Empiricist Accounting 
Has characteristics of scientific talk and writing: treats 
phenomena as agents in their own right and either 
deletes the observer or treats them as a passive 
recipient. 
Rhetoric of argument 
Constructing claims in the form of a logical or well-
known argument type which makes them external to 
the speaker. 
Extreme case formulations 
Can be used to make a claim or report more effect by 
drawing on extremes of relevant dimensions of 
judgement (Pomerantz, 1986)  
Consensus and corroboration 
 
A major way of warranting the factuality of an account 
by depicting it as agreed across witnesses or assented 
by independent observers.  
Lists and contrasts 
Lists, particularly three-part lists can be used to 
construct descriptions which appear to be complete or 
representative. Contrasts formulate a ‘factual’ version 
against a more threatening or unconvincing 
alternative. 
 
Although in Potter & Wetherell’s original approach they undertook analyses of 
interview data, proponents of DP promote the notion that data collected should be 
“naturally occurring” talk or text. The premises being that: the research setting is not 
influenced by the researcher’s own categories, it avoids encouraging people to see 
themselves as disinterested observers of their own actions, it avoids the problems 
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inherent in making inferences from the research arena to the topic or practice, it is a 
rich record of life in practice (Hepburn and Potter, 2007). Other researchers have 
acknowledged the ethical and practical difficulties in obtaining such data (Willig, 
2008). Harper, O'connor, Self & Stevens (2008) in reference to clinical psychology 
research, have suggested that semi-structured interviews can be suitable for DA 
research which aims to “map out” discursive resources available to speakers. 
 
2.1.3.2.3. Foucauldian Discourse Analysis  
Foucauldian Discourse Analysis (FDA) is associated with post-structuralist theory. It is 
concerned with language and the role it plays in constituting elements of life (Willig, 
2008). In psychology, the strand of DA articulated by Ian Parker has its roots in FDA 
(Willig, 2008). Parker (1997) argues that as DP has developed beyond Potter and 
Wetherell’s initial approach, it has become distanced from issues of politics or 
power, making it less critical and more akin to mainstream psychology. He critiques 
the avoidance in DP of locating micro discursive practices in wider discourse. The 
kind of DA articulated by Parker (2005) is concerned with the oppressive versions of 
the world created by discourses, e.g. medical discourses define what is sick. He 
espouses a historically informed analysis which enquires as to how particular 
language has come to organise particular social bonds (genealogy). A key concern is 
with power and its operation to position people through language. Discourse is seen 
to locate people in subject positions which convey certain rights to speak and 
constrain what might be spoken (Parker 1997). Davies & Harré (1990) also utilise the 
notion of positioning whereby discursive practices locate particular subject positions 
and particular subjectivities: individuals can position others or they can position 




2.1.3.3. My approach 
Wetherell (1998 p388) notes the two DA camps in social psychology: approaches 
rooted in ethnomethodology and conversation analysis, which undertake a “fine 
grain analysis” of the “action orientation” of talk e.g. DP; and those developed in the 
post-structuralist tradition informed by Foucauldian approaches where the focus is 
on discourse, power and subjectification. She argues for an integration of influences 
from both strands which will provide “the most productive basis for discourse work 
in social psychology”. Taking this on board and in line with other DA research carried 
out within clinical psychology (e.g. Stevens & Harper, 2007; Harper, 1999) I plan to 
draw on aspects of each of the strands of DA summarised here. Hence in my analysis 
I will pay attention to the following features of talk, which might be considered three 
layers of analysis: 
 The rhetorical devices used by participants in constructing their accounts and 
the functions these serve 
 The interpretive repertoires drawn on by professionals in their talk and the 
subject positions and opportunities for actions these produce and constrain  
 The relationship between the discursive features and wider societal 
discourses (in the FDA sense). 
 
2.2. DATA COLLECTION 
2.2.1. Questionnaire 
2.2.1.1. Construction 
The questionnaire (Appendix 1) was constructed to invite professionals to give an 
account of their practice and present a position on issues in relation to ‘medication 
refusal’. I did not regard the questionnaire as a means of obtaining the “truth” about 
what goes on in services, but as a means of communication between the participants 
and myself (Marks, 2004) through which participants would construct a particular 
version of reality in the context of myself as a Trainee Clinical Psychologist (known or 
unknown to them) inviting such a response. The questionnaire includes questions 
asking for numerical responses, multiple-choice scenario questions and some open-
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ended questions. In utilising a questionnaire which invited participants to select from 
pre-determined responses, I was aware that I was placing my own constraints on the 
accounts it was possible for professionals to provide and artificially de-
contextualising the issues. To balance this to some degree and to provide 
participants with opportunity to ‘resist’ my constructions, I provided free space for 




The questionnaire was piloted by two community mental health nurses (working in a 
CMHT and a community forensic team) who were invited to feedback on how “user-
friendly” it was, how long it took to complete and any questions which were not 
clear. It was also looked at by a clinical psychologist (working in an early intervention 
in psychosis team) and reviewed by the multi-disciplinary “research governance” 
committee of a local NHS Trust. Minor adjustments were made to the questionnaire 
following feedback by these parties.   
 
2.2.1.3. Format 
The questionnaire was converted and distributed in an electronic format using the 
internet company “Survey Monkey” as detailed in Section 2.4.2.1. 
 
2.2.2. Focus Groups 
2.2.2.1. Rationale 
The premise of the focus group is that a small number of people engage in an 
informal group discussion, focused on a particular topic or range of issues, which 
might be presented in various forms (e.g. a vignette, a film). I will briefly outline here 
why focus groups were selected as the means of data collection.  
 
Focus groups are argued to be more ‘naturalistic’ than individual interviews and can 
be used flexibly within diverse theoretical frameworks, including constructionist 
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approaches (Wilkinson, Joffe & Yardley, 2004). They are suggested to be particularly 
useful for exploring “sensitive” topics, for instance Wilkinson describes her work on 
women’s beliefs about causes of breast cancer (Wilkinson, 2008). Kitzinger & 
Barbour (1999) suggest that focus groups enable researchers to examine 
perspectives as they operate within a social network and explore how accounts are 
articulated, censored, challenged and changed through social interaction. 
 
2.2.2.2. Constitution 
There are advantages and disadvantages about the degree to which groups are 
hetero or homogenous. However it has been argued that a group which has a shared 
experience is often the most productive (Kitzinger & Barbour, 1999). Macnaghten & 
Myers (2007) add that it is also helpful if group participants share a certain way of 
talking. Madill, Gough, Lawton and Stratton (2005) suggest that for a student DA 
project, a minimum amount of interview data should be 3-4 hours. Based on these 
assumptions, I planned to hold four uni-professional focus-groups, which reflected 
the main professional groupings in community mental health teams: psychiatrists, 
nurses, social workers and psychologists. I hoped that this approach would create the 
conditions for diverse discursive resources to be drawn on by participants. 
 
2.2.2.3. Vignette & Moderator Schedule 
In order to provide a focus for discussion in the groups, I developed a case vignette 
of a service-user expressing that they were going to stop taking their antipsychotic 
(Appendix 2). I constructed the vignette influenced by case examples in published 
books about psychosis and real cases I had heard about. I aimed the vignette to be 
accessible and familiar to professionals across the different disciplines and types of 
community team. The vignette was reviewed by a community mental health nurse 
and a clinical psychologist for accuracy, plausibility and accessibility. Minor 
amendments were made following feedback. I did not intend that the vignette 
would be the only focus of the discussions, but that it would ease participants into 
discussion around the topic of interest. I developed a flexible interview schedule to 
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use as “group moderator” alongside the vignette to direct discussions in the groups 
around the topic and encourage opportunities for differing accounts to be made 
(Appendix 2).  
 
2.2.2.4. Time & Venue 
One focus group was held on university premises and the others were held on NHS 
premises. They were arranged at locations which were suitable to the professionals 
involved. Two of the groups were held at lunchtime and participants were provided 
with lunch, the other two were held late afternoon and participants were provided 
with refreshments. I had allowed for each focus group to run for approximately an 
hour to an hour and a half. The first two groups (social workers and nurses) lasted for 
just over an hour and the last two groups for just under an hour (psychiatrists and 
psychologists). 
 
2.2.2.5. Session Plan 
The sessions began with welcoming participants, reiterating the information in the 
Participant Information Sheet (Appendix 3) followed by signing consent forms, basic 
ground rules for the discussion and participants reading the vignette. I subsequently 
invited discussion through posing questions on the interview schedule.  
 
2.2.2.6. Role of moderator 
As moderator, although I posed initial questions, I took a relatively less 
“interventionist” stance (Macnaghten & Myers, 2007) in allowing participants to lead 
the discussion in a relatively free way. However, I monitored the degree to which 
participants appeared able to contribute and actively encouraged contributions from 
particular participants at times if it seemed as if some participants were being overly 
dominant. I also encouraged discussion and the expression of differing accounts 
through asking open question such as “have others had the same experience as X 
or..?”. Additionally, I took a “curious” position by at times encouraging participants 





Given the nature of the study and that the participants were all qualified health 
professionals, no significant ethical concerns were identified. Participants were 
provided with sufficient information about the research in order to make an 
informed decision whether to participate (See Appendix 2, 3, 4, 5). All focus group 
participants signed a consent form (Appendix 6). Ethical approval was sought and 
obtained from the Hertfordshire Research Ethics Committee (Appendix 7). No 
objections were expressed and the committee approved the research without any 
amendments. In order to approach NHS staff, approval was sought and obtained 
from the Research and Development departments of the four Mental Health NHS 
Trust from which participants were recruited. The trusts were located in the Eastern 
and London strategic health authority regions. In order to protect the confidentiality 
of participants, the Trusts will not be named here. 
 
2.4. PARTICIPANTS 
2.4.1. Selection Criteria 
The inclusion criteria were: a qualified mental health professional from any 
discipline, working in an NHS community mental health team which undertakes care-
coordination for individuals with psychosis.  Eligible teams were Community Mental 
Health Teams (CMHTs), Early Intervention in Psychosis Teams (EIPT), Assertive 
Outreach Teams (AOT) and Community Forensic Teams (CFT). Individuals working in 
teams undertaking short-term crisis work, but which did not care-coordinate were 
not eligible to participate, as I anticipated that a different range of issues would be 
presented in acute mental health service provision.  
 
2.4.1.1. Survey 
The aim was for the questionnaire to be completed by a variety of professionals in 
the different teams detailed above, so that a diversity of accounts could be collected. 
As there was no plan to undertake inferential statistical analysis on the data 
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collected, there was no target number of questionnaires to be completed beyond 
this aim. In sampling terms, it might be considered a “self-selecting” sample. 
 
2.4.1.2. Focus Groups 
It was planned that four uni-professional focus groups would be held which would 
reflect the main professional groupings in community mental health teams; namely 
psychiatrists, nurses, social workers and psychologists. As such, participants were 
recruited to the focus groups purposively on this basis. Pragmatic decisions were 
made about when to undertake focus groups based on dates which were suitable to 
the majority of potential participants within the time-scale of the project. As such not 




Several strategies were used to recruit participants from the four NHS Trusts to 
complete the questionnaire. Whilst undertaking the research, I was on placement 
within an Early Intervention in Psychosis team in one of the NHS Trusts involved. I 
used the contacts that I had through my position in this team and existing contacts 
through previous work in local services, to cascade information about the research 
and stimulate interest from potential participants, mostly through email. In addition 
the following strategies were used:  
1. Team managers were emailed and asked to distribute the email advert to 
team-members. 
2. The advert was distributed through Trust e-newsletters. 
3. A short pitch about the research was made to four local teams, with email 
follow-ups. 
4. The research advert was distributed to the national membership of the British 
Psychological Society, Division of Clinical Psychology, Faculty of Psychosis and 




2.4.2.2. Focus Groups 
Recruitment to participate in the focus group part of the research was done through 
the questionnaire. The questionnaire asked respondents whether they would be 
willing to participate further in the research by taking part in a focus group, and if so 
for them to provide an email address. Questionnaire respondents who expressed an 
interest and were located locally were contacted and sent an invitation letter 
(Appendix 5). If they continued to express an interest, they were sent the study 
information sheet (Appendix 3). Reminder emails were sent as necessary. Focus 
groups were arranged when there were a sufficient number of eligible volunteers 
available for each group. For logistical purposes, recruitment to the focus groups was 
undertaken from only one of the participating NHS Trusts.     
 
2.4.3. Participant profiles 
2.4.3.1. Survey 
Seventy four questionnaires were completed. Table 2 provides information on 
participant demographics of interest. It shows that there were a good spread of 
participants from the full range of professionals groups, types of team and number of 
years of experience. Of note is the relatively small number of psychiatrists 
participating compared to the number of Clinical Psychologists and Mental Health 
Nurses. Forty three respondents (6o%) indicated that they had a particular interest in 
issues related to “antipsychotic medication, medication withdrawal or non-medical 
approaches to psychosis” (see Appendix 10) and as a whole, participants indicated 
that they undertook a broad range of duties as part of their professional role in their 
team (see Appendix 9). Participants provided information on the size of their 
caseloads, how many of their caseload had had psychotic experiences and how many 







Table 2: Profile of Survey Respondents  



















2. Professional Status 
 Psychiatrist 
 Clinical Psychologist 
 Mental Health Nurse 
 Social Worker 













































































Size of caseload: 20 15 3 – 99 


























1 - 99 
 








12 59 10 63 0 - 75 0 – 100 
 
2.4.3.2. Focus Groups 
Table 4 provides a profile of the participants constituting the four focus groups. All 
participants worked in either a CMHT or EIPT. Attempts were made to recruit 
participants from other types of team, but this was not ultimately possible. The 
reader will note that there was the addition of an occupational therapist to the social 
worker group. This individual was keen to take part and we decided in collaboration 
that being part of the social worker group was the most suitable position, in the 
absence of a group specifically for occupational therapists.  
 
When the focus groups were originally conceived, I had planned for groups to 
contain approximately five or six participants. However, in practice it was difficult to 
achieve these numbers. I decided in collaboration with my research supervisors to 
run groups with a minimum of three participants; Wilkinson (2008) suggests that 
focus groups can be run with as few as two participants, although between four and 
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eight is the norm. The first focus group, which was for nurses, was run with three 
participants. I found that this worked well and rich discussion was had, so I was not 
concerned about later groups being this small.  
 
As I have previously mentioned, decisions about the constitution of the focus groups 
were made pragmatically: the result was that some individuals knew each other in 
groups, some worked in the same team, and some were meeting other group 
members for the first time. Additionally, I knew some participants, worked alongside 
some, and had never met others before. These contextual factors may have 
influenced the ease with which some participants felt able to take part or felt 






























N1 Nurse Band 6 2-5 2-5 
N2 Nurse Band 6 15-20 11-15 









SW1 Social Worker Level 2 2-5 2-5 
SW2 Social Worker Senior 6-10 6-10 
SW3 Social Worker Senior >20 15-20 
SW4 Social Worker Not known >20 15-20 
OT Occupational  
Therapist (OT) 







MD1 Psychiatrist Consultant 11-15 2-5 
MD2 Psychiatrist Staff Grade >20 0-2 







P1 Psychologist Consultant 15-20 15-20 
P2 Psychologist Band 8A 2-5 2-5 




2.5. DATA ANALYSIS 
2.5.1. Questionnaire Data 
The numerical results from the questionnaire were analysed descriptively using 
Microsoft Excel and the summarising facilities provided by Survey Monkey. Open-
ended responses  were examined and categorised. Extracts have been drawn on 
where relevant in order to examine and comment on positions taken by participants.  
 
2.5.2. Focus Group: Stages of data preparation and analysis 
Please refer to Section 2.1.3.3 for more information about the mode of DA utilised. 
 
2.5.2.1. Recordings 
Focus group sessions were recorded using a digital voice recorder. I listened to the 
recordings in their entirety as soon as possible after the groups were held, making 
initial notes on ideas which sprang to mind. 
 
2.5.2.2. Transcription 
I transcribed the first two focus groups in some detail, noting errors of speech, 
stutters, false starts, overlapping speech, pauses of three seconds and over, intakes 
and exhalations of breath, laughter and other non-verbal features, and clear 
emphases in speech. Punctuation was added to ease readability. Due to the time 
consuming nature of the transcription process and the time constraints on the study, 
the last two groups were transcribed by a private company (Appendix 8). I checked 
these transcripts closely against the recordings, corrected errors and added the 
features of speech detailed above. The transcription conventions used are detailed in 
Section 3.3.2. I made further notes of interesting features as I transcribed (See 
Appendix 15 for an example transcript11). After the transcripts had been prepared I 
initially read through each one as a whole at least once, paying attention to what was 
going on in the talk and making more notes. 
 
                                            




Following the guidance of Potter & Wetherell (1987) the transcripts were read 
through and the text was divided into categories which were marked on the 
transcripts. This was an inclusive process, where instances of a category which were 
unclear or vague were still marked as such and extracts of text could be categorised 
under more than one category, as it was not clear at this stage how relevant 
different extracts might be. The process of coding is not seen as being part of the 
analysis, but as being a means through which the data can be divided into 
manageable chunks. An initial list of themes were identified as emerging from the 
data (Appendix 14). Relationships between the themes were explored and they were 
collapsed into broader categories. The extracts of text relating to these categories 
were electronically copied and pasted into separate category files for analysis.  
 
2.5.2.4. Discourse Analysis 
Potter & Wetherell (1987, p175) suggest that there is no method to discourse 
analysis in the traditional sense: it is a “broad theoretical framework concerning the 
nature of discourse and its role in social life”. They suggest that profound changes in 
understanding take place through engagement with and repeated reading of the 
data. The analysis is seen as a fluid process of going back and forth between the 
stages of coding, analysis, validation, writing and back again.  As I became 
increasingly familiar with the data, I found myself in a predicament: the data 
collected was rich with a multitude of potential themes to explore and many possible 
ways forward, such that I was unsure which path to take. This sense of confusion is 
apparently common, particularly for novice researchers (Harper et al., 2008). Potter 
and Wetherell (1987) suggest that the analysis should give coherence to the body of 
discourse and enable the reader to see how the discourse fits together to produce 
effects and functions. I noted that talk about ‘risk’ was a feature in every focus-
group, was being used in rhetorically interesting ways and seemed to lend coherence 
to the body of data as a whole. I made a decision to narrow my focus somewhat and 




3.1. SURVEY RESULTS 
3.1.1. Introduction 
In this section I will present the survey results. I have attempted to present the data 
in such a way that variability in the data are apparent for the reader to see.  
 
3.1.2. How common is antipsychotic ‘refusal’? 
Forty nine participants (66%) indicated that at least one client on their caseload had 
expressed a wish to stop taking or not initiate antipsychotics in the past month 
(mean number of clients = 2; SD = 3). Sixty nine participants (92%) indicated the 
same for the past year (mean number of clients = 5; SD = 5). There was variation 
across respondents in terms of how frequent they reported this experience to be: 
Figures 1 and 2 provide further details of the spread of responses. If we compare the 
proportion of reported incidences of clients ‘refusing’ antipsychotics in the past 
month with the number of individuals on antipsychotics on participants’ caseloads 
(Section 2.4.3.1), we find a mean proportion of 17% (SD = 14; range = 0% - 60%) of 
clients ‘refusing’ per caseload. 
 
3.1.3. Coming off antipsychotics 
3.1.3.1. Past Year 
Participants were asked to indicate how many of the clients in the past year who had 
expressed a wish to come of antipsychotics had started to do so. Forty nine 
participants (71% of those who had reported that a client had expressed a wish to 
stop taking antipsychotics) indicated that at least one of these clients had started to 
come off (mean number of clients = 3; SD = 2; range = 1 - 12). Figure 3 provides 
further details of the variability in responses. On average participants reported that 
40% of clients had started to come off antipsychotics with the support of the service, 


















N = 74 (participants)
Mean = 2
SD = 3 
Range = 0-20
Figure 1: Participant reports of number of clients expressing a wish to stop taking or not initiate antipsychotics in past month 
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N = 74 (participants)
Mean = 5






















N = 55 (participants)
Mean = 3
SD = 2 
Range = 0-12




3.1.3.2. Past two years 
Participants were asked to indicate how many clients they had supported to come off 
antipsychotics in the past two years. Forty four participants (59%) indicated that they 
had supported someone (mean number of clients = 5; median number of clients = 2; 
SD = 10). More details on the spread of the data are shown in Figure 4. As Figure 4 
shows, five participants reported supporting ten or more clients to come off (more 
information is provided about these participants in Table 5, which is discussed 
below), which appears to have inflated the mean, as such the median may be a more 
useful measure here.  
 
A total of 208 clients were identified as having been supported to come off 
antipsychotics in the past two years. Participants were asked to rate the proportion 
of these clients which they deemed to have had a successful outcome for a 
“significant period of time”. A standard definition of success was not provided: 
participants were free to define this. Overall, one hundred and eight cases were 
rated as successful (52%) and 98 were rated as unsuccessful (47%). The mean 
number of reported successful cases per participant was 3 (Median = 1; SD= 3; range 
= 0 – 18); the mean number of unsuccessful cases was 4 (Median = 0; SD=8; range = 0 
– 55). As we can see in Table 5, Participant 67 reported that 55 cases were 
unsuccessful, which has substantially inflated the mean of unsuccessful cases and as 
such the median is a more suitable measure here.  A further calculation was 
undertaken for each of the forty four participants as to their ratings of 
successful/unsuccessful for the cases they identified, as a percentage of the total 
number cases they supported to come off. The percentages were then averaged 
across the group: a 74% ‘successful’ rate was found across participants, with 55% of 
participants reporting 100% success; a 26% ‘unsuccessful’ rate was found with only 




Participants were asked to rate the proportion of cases where the medication 
discontinuation was initiated by them or by the client; the average proportions were 
16% and 84% respectively. 
 
From the perspective of exploring variation in responses and how participants have 
positioned themselves in relation to the questions being asked, it is interesting to 
take a closer look at the five participants who indicated that they had supported ten 
or more clients to come off medication: a more detailed profile is provided in Table 
5. In this sample, a divide is apparent between the psychologists and psychiatrists in 
both the quantitative and qualitative data provided, with the three psychologists 
presenting a more optimistic position with regards to supporting clients to come off 
medication and the psychiatrists suggesting that only a small minority of people can 
manage without medication. For instance Participant 22 (Clinical Psychologist) 
presents a “coming off” success rate of 80% and comments:  “I am developing a 
support pack with staff and service users, for people to use when they are planning 
to stop medication”.  Participant 54 (Consultant Psychiatrist) presents a success rate 
of 10% and comments: “I am not convinced that for all of them is treatment 
























N = 44 (participants)
Total clients = 208
Mean = 5



































EIPS 20 10 10 15 
 
Nice guidelines suggest that following a first episode of 
psychosis, people take antipsychotic medication for at least 12 - 
18 months.  All people who use our service are informed of this 
and following this period many choose to reduce and stop it.  
People are supported to do this but also to restart it if they then 
experience early warning signs of further problems.  Individuals 
feeling empowered and able to actively use medication in this 





EIPS 10 8 2 12 
 
I am developing a support pack with staff and service users, for 
people to use when they are planning to stop medication - but 
the decision to stop is seen as very much to be decided with the 







EIPS 20 18 2 10 
 
These questions are difficult to answer because in our service 
clients may be prescribed neuroleptics for an initial time but then 
be encouraged to come off them for the remainder of their 3 










EIPS 10 1 9 30 
 
Some questions of the questionnaire may be misleading or not 
easy to answer, because people with psychotic experience varies 
in their presentation and I am not convinced that for all of them 
is treatment alternative to medication wise, as it could, in my 






EIPS 60 5 55 5 
 
what about being more specific re diagnosis. I think there will be 
a different approach to someone who has had a brief and self 
limited episode than what a person with a confirmed diagnosis of 
schizophrenia or bipoalr disorder needs. *….+ What struck me was 
that we do not have any proper, reliable follow up studies in F23 





3.1.4. Professional perspectives on why people ‘refuse’ medication.   
Participants who reported that they had worked with someone expressing 
‘medication refusal’ in the past year, were asked to indicate the most common 
reasons people give. They were able to select up to four from a list of 13. They also 
had the option to indicate ‘other’ reasons. Figure 5 depicts the results of this 
question. It shows that the most popular reason selected was “Adverse physical 
effects such as restlessness, un-controllable movements, weight gain, impotence 
etc.”, followed by “Feeling too sedated” and “Feeling better/cured now”. 
Figure 5: Participant selections of reasons people give for not wanting to take 
antipsychotics   
 
N.B. “Other Reasons” given 
all related to the person 
indicating that they are not 
‘ill’, for example “Client does 
not believe they are suffering 





3.1.5. Proposed actions taken if someone ‘refuses’ medication 
Participants were asked to indicate what action they would take if a client expressed 
that they wished to stop taking or not initiate antipsychotic medication. They were 
able to select up to four from a list of 13. They also had the option to indicate ‘other’ 
reasons. Figure 6 depicts the results of this question. It shows that the most popular 
choice was “Explore why..”, followed by “Arrange or encourage an appointment with 
the psychiatrist” and “Discuss with the client the potential risks”. 
 
Figure 6: Participant selections of actions they would take if a client ‘refused’ 
medication 
 
N.B. “Other Reasons” given 
ranged in detail and content: 
three referred to pros and 
cons, 2 referred to discussing 
alternatives to medication. 





3.1.6. Supporting people without medication 
Participants were asked approximately how many clients with psychotic experiences 
they had supported without antipsychotics in the last two years. Fifty five 
participants (74%) reported that they had supported at least one person (Mean 
number of clients = 8; SD = 6; Median = 2; range = 0 -30). More details on the spread 
of the data are shown in Figure 7. Again we can see wide variation in participant 
responses on this question with numbers of people supported ranging from 0 to 30. 
This variation suggests that again the median is a better summary statistic here. 
More information about the one participant (Participant 54) who stated that they 






















N = 70 (participants)
Total clients = 295
Mean = 8
Median = 2
SD = 6 
Range = 0 - 30
 





3.1.7. Confidence in working with these issues 
Participants were asked to indicate on a five point likert scale from “not at all 
confident” to “extremely confident” their confidence in supporting clients to 
discontinue antipsychotic drugs. Figure 8 shows the distribution of ratings. It 
suggests that on the whole participants position themselves as fairly confident in 
dealing with this issue, although a substantial minority (15) position themselves as 
not confident. Participants were asked to indicate what would increase their 
confidence. They were able to select up to three from a list of 8 options. They also 
had the option to indicate ‘other’ reasons. Figure 9 shows the distribution of ratings. 
The most frequent choice selected was “Access to alternative interventions to 
support client”, followed by “Resources to allow me more time to devote to 
supporting clients in this situation” and “More research evidence that clients are able 









Figure 9: Participant selections of what would help improve their confidence in 
supporting clients to discontinue antipsychotic drugs or manage psychotic 
experiences without drugs 
 
N.B. “Other” reasons given 
ranged in detail and content: 
Responses given are 




3.1.8. The relative influence of different stake-holders on decision-making 
Participants were asked to rate to on a five point likert scale from 1 (minimal 
influence) to 5 (most influence), how much influence a range of stake-holders would 
usually have on the decision-making when a client expresses that they wish to stop 
taking or not initiate antipsychotic medication. Figure 10 shows the results of this 
question in terms of relative proportion of each selection made for each stakeholder 
(see Appendix 13). Figure 10 shows that there was considerable variation in 
responses. Overall, the client’s psychiatrist was rated as having most influence 
(average rating of 4.27) followed by the client (average rating 3.87), followed by the 
care-coordinator (average rating 3.65). 
Figure 10: Participant ratings of the influence of different stakeholders on decision-making in 




3.1.9. Non-medical approaches 
Participants were asked an open-ended question about the non-medical approaches 
or support services they provide or are available locally for clients with psychotic 
experiences. A wide variety of responses were provided: Table 6 details the ten most 
frequently listed. Participants were also asked an open question about the non-
medical services/approaches/extra resources they thought would be helpful to have 
locally. A wide-range of suggestions were made, some were suggestions of currently 
unavailable resources, many were related to improving quality, capacity or diversity 
of existing services. Table 7 details the ten most frequently listed.  
 
Table 6: Most frequently mentioned non-medical resources available locally 
Approach or Resource Frequency 
1. “Groups”  
Specified and unspecified.  
Specified included: service-user support, sports, 
“recovery”.  
36 
2. CBT 25 
3. “Psychological Therapy” (unspecified) or Psychology 18 
4. “Support”  
Approach or service. 
16 
5. Family Work 
Included “family interventions”, Behavioural Family 
Therapy, Systemic Family Therapy. 
14 
6. “Hearing Voices” 
Approach or group. 
13 
7. Occupational Therapy  13 
8. “Psychosocial Interventions” 12 
9. Employment or Vocational Services 10 




Table 7: Most frequently mentioned non-medical resources needed locally. 
Approach or Resource Frequency 
1. Increased access to range of psychological therapies 
Specified and Unspecified.  
Specified included: mentalisation approaches, counselling, 
family interventions, dialectical behaviour therapy, CBT. 
21 
2. More community based activities 
Statutory and non-statutory, including day centres, evening 
and weekend activities, OT activities, groups. 
14 
3. More user-led approaches 
Including support groups, peer support networks, buddy 
systems. 
9 
4. Hearing Voices Groups 8 
5. More support services 
Including one to one support workers, befriending. 
6 
6. Medication Support 
More service-user information resources about medication, 
including coming off, medication support forums.  
4 
7. Skills Training 
Anger management, social skills, vocational skills. 
4 
8. More carer/family support services 3 
9. Increased tem resources/less paperwork 3 
10. Alternative forms of service provision 








In this section I have presented the results from a survey of professionals about 
‘medication refusal’. A picture is presented by the participants of antipsychotic 
‘medication refusal’ and discontinuation being a common occurrence. Although, 
there was wide variation in this. Discontinuation was reported to often occur against 
advice.  A majority of participants reported that they had either supported someone 
to “come off” medication or supported someone without using antipsychotics. 
Success rates were reported to be relatively good. On the whole, the participants 
reported themselves as being fairly confident in supporting people without 
antipsychotics. Psychiatrists were constructed as being most influential in decision-
making about medication discontinuation. A wide-range of non-medical 
interventions and resources were identified as being available to participants. Most 
participants indicated that access to a greater quantity and range of such resources 
would be helpful.      
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3.3. DISCURSIVE ANALYSIS 
3.3.1. Introduction 
The aim of this section is present the discursive analysis undertaken of the focus 
group data. Wood and Kroger (2000) discuss the dilemmas involved in how to 
organise a discourse analysis, with possibilities including structuring it around specific 
devises, strategies or functions and presenting it on a case by case basis or across 
cases. They add that data can always be returned to and worked up with additional 
claims at a future date. I decided to structure my analysis across groups, rather than 
examine each group in turn.  I have, however, made observations about differences 
between groups where pertinent.  
 
A concern within discourse analysis, is the relative importance placed on the 
frequency of occurrence of particular features in the data. Harper et al. (2008) 
suggest that the frequency of occurrence is less important than whether a feature is 
culturally available, who said it and in what context it was said. Bearing this mind, I 
have placed more emphasis on the availability and context of particular features 
rather than their frequency.  
 
Mine is not a definitive reading of the data and other researchers might have 
directed their focus elsewhere and structured it differently. I am aware that the 
choices I have made mean that there are aspects of the data which have not been 
attended to, or have not been looked at in depth. I would hope to come back to the 
data at a later date to add to the analysis. 
 
3.3.2. Reading: Some Assumptions 
In presenting a discourse analysis, Potter & Wetherell (1987) state that a set of 
examples should be drawn on, along with detailed interpretations, to link specific 
claims to specific aspects of the extracts. The goal being that the reasoning process 
from the data to the conclusions is documented and can be evaluated by the reader. 
I aim in my analysis to make the basis of the claims I make transparent through a 
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detailed examination of extracts drawn from across the four focus groups. Each 
extract will be presented with original line numbers from the transcript, so that the 
reader can get some sense of where in the transcript the extract was taken from. In 
referencing features of the extracts presented I will refer to line numbers in brackets: 
(50-51). Harper (2008) notes the importance of acknowledging the researcher’s 
contributions in order to provide context to interviews: I have attempted to make my 
role clear in the extracts used and situate each extract in the discursive context in 
which it occurred.  I have at times drawn on wider professional literature to clarify, 
backup or contest claims being made: this will be expanded on in Section 4. 
 
The basic principle underlying a discursive approach is that talk fulfils many functions 
and has different effects (Potter and Wetherell, 1987); that is not to say that this is 
necessarily an intentional process and individuals may be entirely unaware of what is 
being done through their talk much of the time. 
 
To aid the reader, Table 8 summaries the transcription conventions used in the 
extracts and the codes representing the participants.  
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Number in brackets (4) Pause 13 
// 
A turn follows rapidly from another 











An utterance which is impossible to 





A non-speech element such as 








Social Worker 1 
Social Worker 2 
Social Worker 3 
Social Worker 4 
Occupational 
Therapist 
Wor- Utterance is broken off 









*…..+ Excision: some data omitted 
co::lons 
Indicates an extension of the 
preceding vowel sound 
.hh 












Out breath (number of hh indicates 
length) 
……. Speech tails off 
 
 
                                            
12
 See Section 2.4.3.2  for more information about the participants
  
13
 Only clear pauses of >3 seconds were transcribed. 
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3.3.3. ‘Risk Talk’ 
Participants talked implicitly and explicitly about a range of, often conflicting, ‘risks’ 
as being present in the course of their work. I have attempted in my analysis to map 
out the main resources which appeared available to be drawn upon by the 
participants in the focus groups in talking about ‘risk’, in relation to the overall topic 
of discontinuing antipsychotic medication. I have summarised this ‘map’ in Table 9. 
The different strands which I have identified and made claims about are not 
necessarily distinct from each other, rather there are overlaps and complex links 
between them. In this analysis I will not be examining the ‘truth’ or ‘reality’ of the 
‘risk/s’ discussed, rather I am interested in the different ways in which ‘risk’ features 
in the professionals’ accounts to achieve certain rhetorical effects, how it constructs 
and positions different stake-holders and how it warrants certain courses of action 
and excludes others.  
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 The risk to self or others repertoire 
 A Biomedical Construction 
 Adding to the risk: Substance Abuse 








 ‘Risk’ as a ‘disclaimer’ 
 The ‘we can take more risks these 
days’  repertoire 
 The Professional Anxiety repertoire 
 The Duty to Society repertoire 
 The Dilemma Device 
 
 
3. Constructing ‘Coercion’ Vs ‘Freedom 
& Choice’  
 
 
 The ‘Working in Partnership’ 
repertoire 
 Persuasive Talk 
 A question of ‘insight’? 
 
 
4. Constructing ‘Risks’ to Service-Users 
 
 
 Legitimising Vs Minimising the ‘risks’ 
of Medication 




3.3.4. Constructing people with ‘psychosis’ as risky 
Participants constructed people with ‘psychosis’ as posing ‘risks’ to themselves, their 
families, “others” and to professionals. I will explore these claims in this section.    
 
3.3.4.1. The risk to self or others repertoire 
Participants often referred in a characteristic way to service-users posing risks to 
themselves or others, which I have termed the risk to self or others repertoire. 
Extract 1 might be seen as an example of this. It is taken from the beginning of the 
nurses’ focus group when I first invite participants to comment on how they would 
respond in the vignette scenario of ‘Mark’ expressing that he is going to stop taking 
his antipsychotic medication (Appendix 2).   
 
Extract 1: Nurses 
3.  N1: You really have to assess the risk, in terms of eh,  
 under the mental health act. If, if the risk was great enough. (4)  
  M:  What, what factors do you think you’d need to consider in that  
  respect? 
7.  N1: Um, thi this seems ((laughs)) very familiar to me [cos]  
 M:  [mm] 
 N1: I’ve got a patient who I’ve been through this with and he’s on erm  
 oral Risperidone as well and it was the same um dosage as well. Erm,  
11.  ((hhh)) His current mental state? Does he remain psychotic? Is he  
 functioning? Erm. Is he in any distress? Is he a risk um of harming  
  others? Or is he (4) he his current mental state. 
 
Nurse 1 (N1) begins her account in an empiricist14 style referring vaguely to “the risk” 
which “you really have to” “assess” (3). ‘Risk’ is constructed matter-of-factly here as 
a unitary thing which is ‘out there’ to be routinely and objectively “assessed” in order 
to make decisions “under the mental health act”. The lack of elaboration about what 
‘the risk’ is and how it is assessed gives the impression that there is an implicit 
understanding by others present of what is meant. The pause of 4 seconds at the end 
                                            
14 Please refer to Section 2.1.3.2.2 for a definition of this rhetorical device 
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of line 4 suggests that N1 has completed her contribution: further explanation is not 
required. This way of talking helps to rhetorically construct consensus15 amongst 
those present, which, alongside the empiricist style, strengthens N1’s account. Her 
use of the pronoun “you” and modal “have to” (3; my emphasis) add to the 
consensus effect. This is orientated to by the other two members of the group who 
both later on in the discussion refer back to this, for example: “again it depends on 
the risk” (Nurse 2, 17); “And it’s again m- my obligation is to assess that risk” (Nurse 
3, 443). N1 appears to orientate to my question (lines 5-6) as a challenge to the 
consensus, which she responds to by elaborating and further strengthening her case 
(as discussed below).  
 
Reference to the ‘mental health act’ clarifies, for ‘those-in-the-know’, that N1 is 
talking about ‘risks’ posed by service-users such as Mark and consideration of 
hospitalisation “if the risk was great enough” (4). Reference to the mental health act 
and associated terms was a common feature of this repertoire. In making reference 
to the legislation of the mental health act, N1 explicitly positions herself in the 
mental health professional role, a role from which she is entitled to speak about ‘risk’ 
and its ‘assessment’, adding authority to her account. This could be contrasted to a 
service-user, such as Mark, whose authority in talking about such issues could be 
undermined by their non-professional status or by positioning them as ‘mentally ill’ 
(as I show below).  
 
After my question (lines 5-6) N1 switches from the initial empiricist style to a first 
person narrative account; referring to her familiarity with a scenario like Mark’s. Her 
claim that “I’ve got a patient who I’ve been through this with” (9) acts to strengthen 
the plausibility of her subsequent account. N1 returns to the empiricist style by 
listing the “factors” involved in assessing risk. Lists are used as a rhetorical device 
which can give the impression of a complete description; I found that lists of this kind 
often featured in the risk to self or others repertoire and added to the impression of a 
                                            
15 Please refer to Section 2.1.3.2.2 for a definition of this rhetorical device 
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carefully considered sequence of actions, inoculating against possible criticism that 
such decisions are made hastily. 
 
Shorter forms of this repertoire were also present in the focus groups, for example as 
demonstrated by Psychologist 2 (P2) in Extract 2.  
 
Extract 2: Psychologists 
256. P2:  *…..+ Well it’s  
  risk, it’s going back to risk I suppose.  Both for him and his family and  
 other people. 
 
It appears that this repertoire can serve as a ‘bottom line’ argument which can be 
drawn on by professionals to justify their actions, including potentially coercive 
‘treatment’ and as such is extremely difficult to challenge. The repertoire obscures 
the power differentials between professional and service-users to define the ‘risk’. A 
similar repertoire, ‘The life-saving repertoire’, was identified by Stevens & Harper 
(2007) as a justification for compulsory treatment in their discursive investigation of 
professionals’ accounts of ECT.       
 
3.3.4.2. A Biomedical Construction 
‘Psychosis’ was almost always constructed by participants in biomedical terms and 
even if this was not done explicitly, the language used implied this. There were 
numerous references to “illness”, “disorder”, “unwell”, “relapse”, “patient”, 
“treatment”, “diagnosis” in all groups. One effect of this is that it builds a case for the 
obviousness of a biomedical solution, i.e. medication. An exception could be found in 
the Psychologist group where Psychologist 1 (P1) refers specifically to a 
psychoanalytic model of psychosis where it is seen as an 
“adaptation…to..some…profound internal conflict” (33) and there is some discussion 
about the idea of “therapeutic community”. However, P1 goes on to say “who knows 
about the legitimacy or validity of ideas like that” (964-965) and the dominant 




 In Extract 1 (9) we see N1 move from the legal to the biomedical: N1’s use of the 
term “patient” helps to mark this, implicitly defining her contrasting role as ‘nurse’ 
and the expertise inherent in this. Reference to “mental state,” “psychosis” and 
“functioning” (11-13) serves to locate the ‘risk’ within underlying mental illness. This 
provides several functions: it challenges the rationality of Mark’s apparent decision 
to stop taking his medication; it again demarks this as an arena where the expertise 
of a mental health professional such as N1 is needed and her abilities to ‘assess’ such 
‘risks’; and it warrants the continued use of ‘antipsychotic’ medication, if necessary 
through coercion. We see a similar argument constructed by MD1 in Extract 3.    
 
Extract 3: Psychiatrists  
462.  MD1: *…..+ he 
 was never, I understand, aggressive before, explicitly never  
 followed by police or something like that, but, but behaviour  
 seems, if he will deteriorate, it is potential, potential risk yeah.  
466.  ((.h)) So in this case, exactly, I would say that, in ideal world there  
 would be two people to go go go to see the client 
 
In this extract we can see that although MD1 concedes that Mark was 
“never…aggressive” (463) she suggests that there are future risks if he were to 
“deteriorate”. Mark is positioned without agency at the mercy of presumed 
pathological processes and as such the ‘risk’ is an unknown quantity. MD1 suggests 
that as an apparently precautionary measure against the risk Mark might pose to 
professionals, two professionals should be visiting him. Although her reference to 
“ideal world” suggests that this may not happen in practice. The construction of ‘risk’ 
here as being variable and perhaps difficult to measure contrasts with N1’s account 
in Extract 1 where ‘risk’ is constructed as something which is objectively measurable, 
suggesting the flexibility of risk repertoires. However, both forms of the argument 
can serve to warrant caution and potentially more restrictive intervention. The 
82 
 
argument for the variability and unpredictability of risk, by virtue of the assumed 
disease process, potentially warrants greater levels of restriction to more people. 
 
3.3.4.3. Adding to the risk: Substance Abuse 
We saw in Extract 3 the construction of service-users being a risk to professionals. 
Service-users with a psychosis could be further constructed as being more ‘risky’ to 
professionals by reference to their potential alcohol or illegal drug use, as 
demonstrated in Extract 4.    
 
Extract 4: Social Workers 
1051. SW3:  *….+ if you visit  
   someone, and they’re not taking drugs or not abusing alcohol, if  
   they are taking their medication, you’re on a fairly safe bet that 
   when you go and see them at home, you you you feel fairly erm, 
1055. y’know certain that that erm y’know they’re going to be reasonably 
 OK. However if if they’re regularly taking or abusing drugs and  
 alcohol, who knows what you’re gonna find when you// 
SW1:  //Mm// 
1059.  SW3:  //come to the doorstep really *….+ 
 
In this extract Social Worker 3 (SW3) appears to make two main points: (1) if 
someone is taking their medication, they are predictable and less risky (1051-1056); 
(2) if someone regularly uses alcohol or drugs they become an unknown quantity and 
pose potential ‘risks’ to visiting professionals (1056-1059). Although we can see that 
SW3 is somewhat hesitant in his first claim: “you you you feel fairly erm y’know” 
(1054-1055) and hedges his argument (“fairly” and “reasonably”) possibly suggesting 
the problematic nature of this claim.  
 
Service-users here are attributed agency: they can take or not take prescribed 
medication and can take or not take drugs and alcohol. Being attributed agency 
allows for judgements to be made about whether behaviour is ‘responsible’ or 
‘irresponsible’. The implication here is that taking prescribed medication is 
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responsible and taking drugs or alcohol is irresponsible. There are thus discursive 
resources available for professionals to blame service-users for their actions and 
‘riskiness’. There was also an alternative repertoire of optimism around service-users 
with a diagnosis of ‘drug-induced psychosis’. Here ‘psychosis’ could be located as a 
consequence of drug-taking with the presumption that if drug-taking stopped, the 
psychosis would relinquish, without the need for long-term antipsychotic 
‘treatment’: “very often they’ll come off the medication and never relapse as long as 
they look after themselves by not taking drugs again” (Nurse 1; 498-499). Again the 
service-user is being attributed agency and responsibility: in this case for preventing 
future ill health.  We can also see here the influence of ‘diagnosis’, which is 
elaborated on in the next section.  
 
3.3.4.4.  The diagnosis as a measure of risk repertoire 
‘Diagnosis’ was a further resource available for participants to draw on in their 
construction of ‘risk’ posed by service-users. Extracts 5 & 6 demonstrate the 
different ways in which this might be done.  
 
Extract 5: Psychologists 
173.  P1: *…+ but I find myself over responding or  
 responding in a more erm active way with clients in this position  
 (compared) to clients with other diagnoses. 
.  M: Right. 
177.  P1:  The diagnosis becomes a very heavy part of the ((.hh))// 
 M:  //Mm// 
 P1:  //gravitational field. 
 
In Extract 5, Psychologist 1 (P1) is responding to my question about the relative 
influence of ‘risk’ in responding to Mark’s case (following a prior discussion of ‘risk’ 
by the group). In his first person account he positions himself without agency 
“finding” himself “over responding” to the “diagnosis” (173-175) which is attributed 
agency. The metaphorical comparison to “gravity” (177-179) constructs a psychosis 
84 
 
diagnosis as a powerful force over which one has no control but can observe its 
effects. As such P1 is suggesting that he is an innocent bystander and cannot be held 
accountable for his presumption of ‘risk’ and subsequent “over response”. The term 
“over respond” is vague and perhaps glosses actions which P1 might not want to be 
associated with as a psychologist, who might usually construct himself as an ally of 
the “client” (as psychologists do elsewhere in the focus group). In locating agency 
within ‘diagnosis’ he is able to inoculate against possible criticism for his “over 
response”.  
 
One could also read P1’s account as locating agency in psychiatrists who would be 
the authority giving the diagnosis. If we read it this way, we can see that this account 
is denying responsibility for constructing service-users with a psychosis diagnosis as 
risky and allocating blame at the door of psychiatry. Given this reading, it is 




Extract 6: Psychiatrists 
950.  MD3:  But that’s why it’s important, the assessments, get the initial  
 assessment// 
 MD1:  //Yeah yeah yeah// 
MD3:  //as soon as possible, you should know, what kind of patient you  
954.  are going to treat. 
MD1:  Yeah ((softly)) 
M: And what ((hh)) I don’t know, what, what would you be thinking in,  
 in terms of, w- would it point you in different directions? 
958.  MD3: O- o- Obviously take more risks, because um, maybe just that it, it’s  
a transitory situation, err, stress disorder, uh, acute something,  
acute, lets say psychosis in a person who otherwise is not  
 psychotic. 
962.  M: Mm. 
MD3: There are, psychiatry is not a, so clear as all// 
 MD1: //Yeah yeah// 
MD3: //so we can make mistakes all the time, uh, [we..] 
966.  MD2:  [No litmus,] litmus test they call it you know// 
M:  //Mm// 
 MD2:  //you can’t test it, this problem. 
 MD3: But if you are in front of you (xxxx) a paranoid schizophrenic  
970.  patient// 
 MD1:  //Mm// 
 MD3: //you know that this guy has to take medications// 
 MD1: //Yeah// 
 
In Extract 6 MD3 like N1 in Extract 1 constructs ‘risk’ as being something which can 
be objectively assessed, in this instance by virtue of the diagnosis: “you should know, 
what kind of patient you are going to treat” (953-954) because depending on the 
diagnosis you can “O- o- Obviously take more risks” (958). MD3 then makes a 
rhetorically interesting argument in which he shows what Antaki and Wetherell 
(1999) term “concessions”. He shows concession to the possible counter-argument 
that diagnosis is unreliable: “psychiatry is not a, so clear” (963); “we can make 
mistakes” (965). He is joined in this concession by Psychiatrist 2 (MD2): “No litmus, 
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litmus test” (966). We can then see what has been termed a concessionary marker: 
“But” (969). This marks the end of the concession and indicates that what follows is 
contradictory. He goes on to restate the original proposal that diagnosis indicates 
risk, by using the example of “a paranoid schizophrenic patient” (969), which he is 
suggesting is a clear-cut diagnosis, concluding categorically that such a patient “has 
to take medications” (972). The use of the modal “has” again sets the scene for 
potentially coercive action. 
 
Antaki and Wetherell suggest that including a concession strengthens an argument 
by making it less open to challenge. MD3’s argument is further strengthened by his 
category entitlement: as a psychiatrist he has the authority and expertise to make 
such diagnoses. We can also see here elements of a tautological argument: how do 
you know this person is risky: because he is a paranoid schizophrenic: how do you 
know he is a paranoid schizophrenic: because he behaves riskily. We can see how it 
would be very difficult for a service-user to challenge the case being made here.       
 
3.3.5. Constructing Professional ‘Responsibility’ 
We saw in my analysis of N1’s account in Extract 1 that she presented ‘risk 
assessment’ as being an obligatory part of her ‘role’. In this section I will further 
examine the accounts the participants gave about their ‘roles’ in relation to ‘risk’, 
particularly in constructing professional ‘responsibility’.  
 
3.3.5.1. ‘Risk’ as a ‘disclaimer’ 
Hewitt and Stokes (1975) frame a ‘disclaimer’ as a verbal device which is used ‘ward 
off’ potential attributions of an undesirable identity or characteristic in what is about 
to be said, for example “I’m not racist but”. Focus group participants seemed to draw 
on ‘risk’ as a disclaimer, as I have underlined in Extracts 7&8.  
 
Extract 7: Nurses 
382.  M:  So if in, you talked *N3* about, theres some instances where, people  
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 do stop taking their medication. ((.hh)) Would there be situations 
 where you would actively, support that or or agree to disagree// 
N3: //Erm//        
386.  M:  //But// 
N3: //There are situations where I would actively support that//  
N1: //Mm 
N3: And obviously you take in mind the risk, the legal status, 
 
Extract 8: Psychologists 
250.  M: So there’s part of you that would want to support what he’s saying,  
  but// 
P2: //Mm// 
M:  //part of you that feels like there’s nothing there to support that// 
254.  P2: //Yeah// 
M: //that decision, for him. 
P3: Yes, that I I would want to um, make sure that he would.  Well it’s risk, it’s going 
back to risk I suppose. *….]  
 
The form of the disclaimer I identify is somewhat different to the classic form 
described by Hewitt and Stokes, but none-the-less appears to serve the same 
function, in this case as an apparent attempt to defend against the accusation of not 
behaving responsibly. In both of these examples Nurse 3 (N3) and Psychologist 2 (P2) 
use the ‘risk disclaimer’ when I question their position on potentially supporting 
service-users who want to stop taking medication. It appears that to readily take a 
supportive position in this respect can be problematic for professionals and my 
reading is that this is because of the potential for this position to be constructed as 
professionally irresponsible.   
 
3.3.5.2. The ‘we can take more risks these days’ repertoire 
The ‘talk’ drawn out from the groups and presented so far has on the whole 
constructed ‘risk’ as something to be avoided and this was the dominant 
construction. However, there were accounts where ‘risk taking’ was talked about. 




Extract 9: Social Workers 
417. M:  So given the boundaries of the systems in which you work, do you feel you can 
respond as you’d like to in these this kind of situation? 
(4) 
SW1:  Yeah, I, ((hesitantly)) [think so yeah] 
421. OT: [I feel I feel I think we,] I personally do I think we can take some more risk 
because we’re practitioners and we’re given more autonomy as practitioners 
nowadays than, than we used to. I think it was very much dictated by medical 
staff and I think that we have more, control over that. I I might I might be having 
a different  
425.   experience than other people. 
 
Extract 10: Psychiatrists 
1054. MD2: I mean in the current situation, you’ve got more resources at the  
moment, that we can follow them regularly you know, so we can  
take a chance you know, take a risk// 
 M:  //Mm// 
1058. MD2: //to reduce the medication and see, how they respond, whether it  
  gets worse or whatever (xxxx xxx xx).  Previously it used to be so  
  difficult people used to be on depot medication, Modecate or Haldol  
  and they carried on for many, many years, even if they were  
1062. symptom free//  
 M:  //Mm// 
MD2: //they were settled. But they used to go and the GP used to give  
 them depot medication and (they were on it for twenty years). Even 
1066.  though we have got recently atypical antipsychotic treatment, they  
 carried on taking (all) injections. But because we are now  
 monitoring, its more community team you know approach, so now  
 we are monitoring more closely, so we can take more chances and  
1069. do the experiment as well. 
 
In Extract 9, I ask the group whether they are able to respond to Mark’s situation as 
they would want to (417-418), thus inviting a possible discussion of the service 
context in which they operate. The pause of 4 seconds and SW1’s hesitant response 
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(419-420), suggests that this is a possibly problematic question. Occupational 
Therapist (OT) also begins hesitantly (421) and struggles to find her footing (“I feel” “I 
think”). She apparently continues more confidently: “I personally do” (421) but this, 
along with “I might be having a different experience than other people” (424-425) 
acts as a hedging disclaimer (Hewitt and Stokes, 1975). The function of this is to 
suggest uncertainty about what is being said: this is only her experience, which 
perhaps allows for some flexibility in her position, depending on the responses of 
others. OT’s qualifier “some more risk” (my emphasis) adds to the tentativeness of 
her claim. The main thrust of her argument is that non-medical professionals like her 
have more say in issues related to medication than in the past which could lead to 
more risks being taken in working with service-users without medication. OT does 
not offer an explicit evaluation of whether this is a positive or negative change, but 
the suggestion is that this is a good thing.  
 
In Psychiatrist 2’s (MD2) account in Extract 10 he also claims that more risk can be 
taken now than in the past with regards to reducing the amount of antipsychotic 
medication people take. He is more confident in his claims than OT, implying 
consensus with his use of the pronouns “you” and “we” and his accompanying 
detailed explanation as to why more risk can be taken now. He presents the case of a 
modern service with “resources” which allow service-users to be followed “regularly” 
(1054-1055) by the “community team” (1065) and that there is opportunity to 
“experiment” (1069) to “see how they respond” (1058). He also claims that this 
progress is due to changes in the way that medications are administered: the shift 
from “depot medication” (1060) to “atypical antipsychotic treatment” makes it 
easier for medication to be reduced. MD2 rhetorically strengthens the apparently 
factual nature of his account through the use of contrast: he vividly contrasts current 
practice with how things used to be: “people used to be on depot medication, 
Modecate or Haldol and they carried on for many, many years, even if they were 
symptom free” (1060-1062). MD2’s account is rhetorically skilful in the way that 
current practice is owned and taken responsibility for through the use of “we” but he 
90 
 
distances himself and his psychiatry colleagues from other types of practice both 
temporally and through the non-agentive quality of his portrayal: “people used to be 
on” not “we used to put people on”. MD2 goes on to locate responsibility for these 
past practices with GPs (1064-1065) and in doing so absolves psychiatry of any 
responsibility. MD2’s account thus obscures possible counter claims that 
antipsychotics have always been available as oral preparations and that significant 
numbers of service-users are still prescribed depot medication by psychiatrists (one 
study found rates of between a quarter and a third: Barnes, Shingleton-Smith and 
Paton, 2009).  
 
We can see that apparently progressive accounts of ‘risk-taking’ practice are actually 
rather weak accounts which operate purely through a comparison to previous 
practices: in OT’s case prior medically dominated practice and in MD2’s case previous 
over-use of depot medication. Another take on ‘risk-taking’ is demonstrated next. 
3.3.5.3. The Professional Anxiety Repertoire 
Participants drew upon the notion of “anxiety”, “worry” or “stress” in particular ways 
in their accounts, which I have termed The Professional Anxiety Repertoire. 
Discursive psychology approaches examine how emotions are invoked in accounts 
and the discursive functions such invocations serve (Edwards, 1999). In Extract 11 we 
can see an exchange between SW3, SW1 and OT, taken from a sequence in which 
they are talking about the greater choice given to service-users about taking 
medication in the early intervention in psychosis team, compared with other mental 
health teams.  
 
Extract 11: Social Workers 
462. SW3: [..] there is an expectation that we will be working with clients//  
OT:  //yeah// 
SW3: //with quite a level of being quite unwell actually// 
SW1:  //Mm [yeah, yeah]  
466.  OT:  [Yeah uh yeah] 
SW1: we can be very worried at home and [missing out on sleep] 
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OT:  [((laughing)) yeah] 
SW3: [((laughing)) (xxxx)] 
470.  SW1: yeah but yeah I certainly can get y’know can get very anxious// 
OT:  //Yeah// 
SW1: //and [you can]  
SW3:  [Yes] 
474.  SW1: take it home with you but yeah you’re still working with them in the 
community// ((sarcastic tone)) 
 
SW3 claims that “there is an expectation that we will be working with clients with 
quite a level of being quite unwell” (462;464). SW3 is talking collectively through his 
use of the pronoun “we” and as such is inviting consensus from his colleagues which 
they respond to. Although it appears initially that SW3 might be presenting a positive 
picture of a progressive way of working, as this exchange develops this reading is 
undermined. SW3 modifies the extent of his claim for the ‘unwellness’ of clients 
through the double use of “quite”, perhaps to defend against perceived accusations 
of irresponsible practice (464) and locates decision-making as outside of his and his 
colleagues’ hands through his suggestion that “we” must comply with “the 
expectation” (462). SW3 is constructing himself and colleagues as powerless and at 
the mercy of the “expectation” of unidentified forces ‘out there’ making demands on 
them. SW3’s vagueness16 about where the “expectation” is from might be seen as an 
implicit criticism of someone or something which SW1 and OT will be able to 
decipher from their shared local knowledge or it might be used as a device to guard 
against disputation.  
 
SW1’s subsequent response builds on this and suggests agreement with the premise 
of SW3’s claim. However, she appears to dispute its moderateness by drawing on 
emotional lexis. The argument being made appears to be that, contrary to SW3’s 
suggestion that there is an expectation to work with people who are “quite” 
“unwell”, people are so unwell and so much of a risk that professionals “worry” 
                                            
16 Refer to Section 2.1.3.2.2 for a definition of this rhetorical device. 
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about them at home, to the extent that they lose sleep (467). SW3 and OT orientate 
to this claim with laughter, suggesting that this is made as a joke (468-469). SW1’s 
use of humour here may suggest an acknowledgement that what is being said is 
contentious. The acceptance of her contentious claim through laughter permits SW1 
in her next utterance to restate her point in stronger language (“certainly”; 470) 
using the pronoun “I” this time. There is another pronoun shift to “you” as SW1 
completes her contribution, which serves to distance her personally from what is 
said next (474-475). She uses humour again to apparently criticise the idea of 
‘community care’ and the unreasonable demands this places on professionals like 
her (“you can take it home with you”; 472-474). Griffiths (1998) demonstrates how 
humour is used as a device in community mental health team meetings to resist 
medical dominance without overt challenge to authority. To overtly criticise the 
principles of service-user choice and community care would place SW1 in a 
problematic position, however the careful and complex use of humour and 
emotional lexis allows this critique to be made. The effect being to evoke empathy 
for the professionals who are bearing the weight of too much responsibility, 
indirectly blame the service-user for making an unwise ‘choice’ about medication 
and blame the system which allows this state of affairs. We can also see here that 
through the implied blame of service-users for choices they make, they are being 
attributed agency. This contrasts with the lack of agency attributed to professionals 
by SW3 at the beginning of the extract and the passive apparently natural “anxiety” 
response to unrealistic demands being placed on professionals.   
 
3.3.5.4. The Duty to Society Repertoire 
It was implied in some accounts that professionals have a responsibility to protect 
society from the risks posed by service-users. This theme was strongest in the 
discussions in the social worker group. An explicit example of this repertoire can be 




Extract 12: Social Workers 
1226. SW2:  *…..+ mainly I think we have expectation on 
 us that from society that that we’re to keep people well and to  
 keep people safe ((.h)) and when when you ask what, what would  
 help, I mean, in the case of this Mark guy, y’know it would be nice  
1230. to be able to try but but there’s a lot of pressures on us 
 *….+ 
1235.   through whatever  
  reason, medication seems to be y’know whether its that’s its got  
  the evidence backing it or it but that seems to be the first line of  
  treatment really and that’s what y’know erm that’s the one we  
1239.  tend to use.          
 
Extract 13: Social Workers 
1266. SW2: *…..+ an example would be and this is an extreme  
 example, but erm we get referred for someone in in a similar  
   situation erm who y’know he’s responding like this, erm but saying  
 he’s not going to take his medication er and this is extreme, erm  
1270.  and we er it got to a mental health act assessment and it and he  
 was clear so so so the worker and the doctors tried to, tried to erm, 
  s- support him with that so they didn’t force the medication they  
 thought they’d keep things under review for a week and the wor-  
1274.  worst possible thing happened, he he erm he he was getting lots of  
 similar to people laughing about him// 
M:  //Mm// 
SW2:  and and he got in a car and drove to London and ran some people  
 1278.  over// 
SW1: //Oh// 
SW2: //killed some people so. I mean y’know it was in all the national  
newspapers and things like that// 
1279. M:  //Mm// 
SW2: //and that that its not useful cos its so extreme [but] 
M:  [Mm]                   
SW2:  y’know it is very hard to think, y’know you are working within (this)  





In Extract 12, SW2 is contributing to a discussion about alternatives to antipsychotic 
medication, invited by a question I ask about this. In contrast to SW3’s account in 
Extract 11 that there is an “expectation” to work with people with “quite a level of 
being quite unwell” (462-464), SW2 suggests that there is an “expectation” from 
society that “we’re to keep people well and to keep people safe” (1226-1228). In the 
use of the word “people” in relation to safety, SW2 could be referring to keeping 
service-users “safe” from society or keeping society “safe” from service-users: his 
narrative in Extract 13 suggests the latter (discussed further below). SW2 makes a 
weak concession that there may be alternatives to medication which might be 
helpful (“it would be nice to be able to try”; 1230), but due to the “pressure on us” 
(1230) medication is the best option. SW2 is vague about the “pressure” and about 
why medication is the best option. As we have already seen, vagueness can be used 
to evade scrutiny and rebuttal. The “pressure” may refer to pressures from society, 
from the service or pressures of workload, amongst others. The reference to “the 
evidence” (1237) has the rhetorical effect of adding credibility to the claim, but again 
the lack of specificity defies easy challenge. As we have seen in other accounts, SW2 
seems to be denying agency in decision-making, on this occasion by suggesting that 
there are good reasons for the way things are currently and that he is in essence 
following the protocol of the service he works in: “through whatever reason *…+ 
that’s the one we tend to use”.   
 
The main thrust of SW2’s claim is that there is an expectation from society that 
mental health professionals have a responsibility to “keep people” with mental 
health problems “well” so that society is kept safe and that medication can do this. 
The implication here again is that potentially coercive medication ‘treatment’ is 
warranted. We can see a stronger case made for this if we examine Extract 13. 
 
In Extract 13 (in the context of a discussion about professional accountability which 
develops from SW2’s account in Extract 12) SW2 tells a story which is used to 
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exemplify his argument in Extract 12. Although the terms narrative and story are 
often used interchangeably (Sarbin, 1986), the story has been characterised by some 
commentators as a particular type of narrative genre (for example: Kohler-Riessman, 
1990; Mishler, 1986). Features of a story include: a temporal dimension; a beginning, 
middle and end; a ‘plot’, central to which are human predicaments and attempted 
solutions; and a coherence or connectedness of events (Sarbin, 1986; Gergen & 
Gergen, 1986). We can see that SW2’s account in Extract 13 contains all of these 
features, and narratives meeting this definition were a frequent feature throughout 
all of the focus groups: SW2’s story was one of the shorter and less detailed 
examples.  
 
Both the employment of the story by SW2 at this point and the way in which the tale 
is told have particular rhetorical effects.  Kohler-Riessman (1990; p1197) argues that 
stories are particularly powerful in their ability to “pull the listener into the teller’s 
point of view.” Similarly, Edwards & Potter (1992) locate narrative as a device which 
can add to the plausibility of an account. We can see that SW2 makes a repeated 
claim about the story before and after telling it that it is an “extreme” example 
(1266, 1269, 1280). We have seen previously how the use of concessions like this can 
strengthen accounts (Section 3.3.4.4).  The story is given authenticity by the 
suggestion that SW2 was a close observer to the events by virtue of being a member 
of the team in question: “we get referred for someone” (1267). We see SW2’s story 
is gradually worked up through setting a typical scene of a referral to the service, the 
introduction of the service-user saying he won’t take medication, a failed attempt to 
section the protagonist, and events subsequently culminating in a tragic and 
shocking ending as the unmedicated service-user gets into a car and runs over and 
kills “some people”. The inevitable trial by press ensues. And the moral of the story is 
that “you do have responsibilities” (1283) as a professional because if you don’t take 




There is little context provided to the events or efforts to develop the main 
character, by providing a background history. This vagueness adds to the impression 
of a clear cause and effect between being “ill”, not being medicated and high levels 
of risk.     
 
3.3.5.5. The Dilemma Device 
Extract 14 is interesting in the way some of the analytical observations made already 
in this section are drawn together in the form of a dilemma. Psychologist 2 (P2) is 
responding to a question from me to the group about whether they are able to 
respond as they’d want to in Mark’s case.   
 
Extract 14: Psychologists 
208. P2:  It’s an interesting question.  It’s all going through my mind is there’s  
 part of me that would encourage him to, if he really felt strongly  
 against medication, I would encourage him to go with that.  But then  
 there’s another part of me that thinks, yes, but I wouldn’t be there  
212.  as an emergency service if things went wrong.   
P1:  Yeah. 
P2: And, so there’s part of me that takes a- feels a responsibility towards  
 the team as a whole *….+ 
224.  *….+ but it’s this emergency service, that  
 we’re actually not there all day or night, 
M:  Hmm. 
P2:  um, if there is then a crisis.  So I suppose it’s trying to be responsible  
228.  for the team as a whole.   
 
P2’s initial response “its an interesting question” (208) might be seen as a delaying 
tactic, perhaps suggesting the problematic nature of the question. P2 goes on to 
present a dilemma between supporting and encouraging Mark in refusing the 
medication (209-210) and not wanting to cause difficulties for “the team” if it goes 
wrong (212-215). P2 goes on to repeat the terms of this dilemma (extract not 
included) before concluding with “So I suppose it’s trying to be responsible for the 
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team as a whole” (227-228). We can see that P2 does some interesting rhetorical 
work in this extract as she struggles to position herself and give an account which, 
one might speculate, can guard against others potentially attributing her with an 
undesirable identity, such as: “irresponsible”, “risk-averse”, “a bad team-member”, 
et cetera.  
 
P2 presents an image of an argument between the two contradictory positions being 
played out in her “mind” (208). She talks metaphorically of embodying the dilemma: 
“there’s part of me that would encourage him” (208-209), “there’s another part of 
me that thinks, ‘yes, but I wouldn’t be there…’” (211). The metaphor allows P2 to 
vividly demonstrate the dilemma between the two positions, which creates the 
impression that there is a very difficult decision to be made here and that she 
wouldn’t make it lightly. In demonstrating that she has an awareness of the different 
positions available, P2 is able to defend the position she finally takes as being the 
process of a series of reasoned arguments. If we look at the argument being made by 
P2, we can see that she draws on certain devices which serve to make her final 
position seem more reasonable. For example, she positions the alternative in terms 
of an extreme case formulation (Pomerantz, 1986). She implies that the most likely 
consequence of Mark coming off his medication would be an “emergency” or 
“crisis”, which she wouldn’t be able to deal with because “we’re actually not there all 
day or night” (225). The argument being made is that it would only be safe for her to 
support Mark to stop taking his medication if she could be there “all day or night”. 
This talk of extremes helps P2 to rhetorically reach the conclusion that her 
responsibility lies with the team, but also that in taking this position she is acting in 
Mark’s best interests because to allow him to go into crisis and not be able to do 
anything to support him would be irresponsible. P2 marks her conclusion with 
qualifiers (“suppose”, “trying”) which gives the impression that this is a position 




It is important to draw attention here to a repertoire evident only within the 
psychologist group which might be seen as super-ordinate to other discussions held 
in this group. Much of the talk hinged on debating the relevance or usefulness of 
psychologists getting involved with matters to do with medication. I might term this 
repertoire the ‘do we even have a role in this’ repertoire. This is exemplified by 
Psychologist 1’s comment: “I think sometimes we’re seen as being um err, 
unhelpfully irrelevant in these situations” (370-371). Although alongside this was a 
counter-repertoire along the lines of ‘psychologists have valuable contributions to 
make’ which can be seen in Psychologist 3’s comment: “hopefully um, kind of 
broaden the understanding of the issue” (517-518). The second repertoire appears to 
be reflected in Holmes account detailed in Section 1.8.5.2 and some of the 
questionnaire responses (Section 3.1.3.2).   
 
3.3.6. Constructing ‘Coercion’ Vs ‘Freedom & Choice’  
I have already used the terms ‘coercion’ and ‘coercive’ in reference to points I have 
made in the preceding sections. It may be useful to draw on definitions at this point. 
The Oxford Dictionary (Hornby, 2000 p229) defines coercion as “the action of making 
somebody do something that they do not want to do, using force or threatening to 
use force”. The rationale for coercive treatment under mental health legislation is 
bound up with the notion of ‘risk’ and we saw this being drawn upon explicitly in 
Section 3.3.4.1. The opposite pole to ‘coercion’ might be seen as ‘freedom and 
choice’. In this section I will examine more closely the interplay between these poles.  
 
3.3.6.1. The “Working in Partnership” repertoire 
A repertoire of professionals working in partnership with service-users was drawn on 
throughout the focus groups. In Extract 15 N2 is talking about how she would work 




Extract 15: Nurses 
21.  N2: *…+ I think if he was managed in the community  
 I’d be looking at trying a different medication and getting him to  
 actually work with me towards finding the right medication. Because  
 I think even if somebody goes straight to hospital, um, they’re forced  
25.  to take medication basically when they come home they can be non- 
 compliant again. So I think its about, them managing their own  
 medication and working in partnership together. 
 *….+ 
 45. because its quite empowering for them//  
 M:  //Mm// 
  N2: //to have a say rather than to have all of that taken out of their  
  hands.  
 
N2 begins the account with a conditional “if he was managed in the community” (my 
emphasis; 21) suggesting that Mark being seen in the community is not a given: the 
possibility of hospitalisation is always there. The term “managed” is interesting in 
that it positions Mark as less powerful, but doesn’t exclude the possibility of some 
agency (we see this below). The power inherent in ‘managing’ is not located in 
anyone at this point, but then is made clearer as N2 places herself in this position: as 
she moves to talk in the first person: “I’d be” (22), “work with me” (23). The phrasing 
“work with me” is prefaced by “getting him to” suggesting that this is something that 
will require some effort on her behalf and hints at coercion. N2 constructs the 
“work” which she and Mark will do as “finding the right medication” (23). This is 
counter to Mark’s expression (in the vignette) that he does not want to take 
medication and doesn’t like taking it. N2 has hence already formulated that the 
problem is that Mark is on the wrong medication and that the situation would be 
resolvable if the “right medication” (my emphasis) were to be found. She is thus 
taking a paternalistic position (Day and Bentall, 1996): she is the expert who knows 
better than Mark: medication is the solution to Mark’s predicament. The notion of 
professionals knowing best appeared to be questioned by an anecdote told by N3 of 
a service-user who successfully came off his medication against N3’s advice: “…its 
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over a year now er. Things have remained well. This, lads, been at university and got 
a degree in the mean time..” (304-305). The possibility of this potential ‘service-users 
as experts’ repertoire to challenge the dominant repertoire of paternalism 
demonstrated in Extract 15 was undermined as N3 went to add that “..but (actually) 
its hard to compare like for like really isn’t it they’re all different stories..” (305-307). 
Hence it is dismissed and minimised as a one-off, maintaining the dominant 
narrative. 
  
N2 goes on to compare her approach with what would happen if Mark was sectioned 
and “forced to take medication” in hospital, as the problem would be that once he 
came home he could be “non-compliant again” (24-26). This part of the account is 
interesting rhetorically, firstly the comparison with the extreme coerciveness of 
hospitalisation serves to position N2’s community approach as more humane and 
reasonable, and secondly N2 is formulating Mark’s concerns as “non-compliance”. As 
I discuss in Section 1.8.2, “compliance” is a dis-preferred term in the professional 
literature now, because of the implied passivity of the service-user and expectation 
of obedience to medical authority. There is then a further interesting move 
rhetorically, as N2 gives the impression of handing back full agency to the service-
user: “its about, them managing their own medication” (26). N2 has thus proposed 
an interaction with Mark where she has set that the agenda is “finding the right 
medication”, that Mark has to work with her towards this, which will then lead to 
Mark “managing” his “own medication”. Mark “managing” his own medication infers 
agency and choice, but we can see that the inferred ‘choice’ is illusory because 
actually the expectation is that Mark complies by taking the medication others 
prescribe him to take. Attributing Mark agency here means that he can then be 
blamed for not taking the medication and not ‘getting better’ as opposed to blaming 
the medication for not having the desired effects.  N2 then glosses the process she 
has described as “working in partnership together” (27). As “partnership” usually 
implies equality between partners, we can see that this is also illusory as N2 has 
already set the terms of the engagement. N2 adds to the gloss later by referring to 
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her approach as “empowering” (45). However we can see it is only constructed as 
such by virtue of its comparison to the opposite extreme: “rather than to have all of 
that taken out of their hands” (47-48).  
 
3.3.6.2. Persuasive Talk 
Participants’ frequently talked implicitly and explicitly about “persuading” service-
users to take medication: a practice which has been alluded to by service-users 
(Rogers et al., 1998;  Section 1.7.2.2). An example of this can be seen in Extract 16. 
  
Extract 16: Nurses  
479. N2: *…+ Wh- as I said  
  earlier, I think what I would like to do is to try and y’know talk him  
  into trying something different.  
 
In Extract 16 Nurse 2 (N2) is making reference to Marks’s case. In this example N2 is 
talking explicitly about persuading Mark to take his medication: “talk him into trying 
something different” (480-481). N2’s use of “y’know” (480) suggests that this is an 
accepted thing to do.  In Extract 17 we can see a typical account of how the 
persuasion might be done. Again Social Workers 3 (SW3) and 1 (SW1) are making 
reference to Mark’s case. SW3 had said previously that he would take a “relapse 
prevention stance” (20-25) and he is responding to my question about how he would 
do that.     
 
Extract 17: Social Workers 
29. SW3: [by going] over with him some of the, symptoms that y’know he’s// 
SW1: //so the early warning signs?// 
 SW3: //Yeh, the early [warning signs really] 
 SW1: [Yeah] 
33.  OT: Yeah 
 SW3: that are likely to occur// 
SW1: //yeh// 
SW3: //should he stop his medication really. So its its kindof (3)  
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37.  encourage him really// 
SW1: //yeah// 
 SW3: //that y’know this could happen if you stop taking your medication  
  and erm y’know remind go over with him really about some of  
 41.   those feelings that he experienced and er, I suppose its a kind of  
  like a kindof subtle way of [trying to persuade him] 
SW1: *Mmm…..yeah+ ((softly)) 
SW3: to carry on. 
 
In Extract 17 SW3 begins his explanation with “by going over some of the symptoms” 
(29). Harper (1999) has coined the term symptom-talk which he defines as being a 
form of narrative where the focus is:  
 
a narrow range of observable and inferred phenomena (symptoms) and which views these 
phenomena as both possessing agency and being 'surface' signs or markers of 'deeper' 
pathology (i.e. illness or disease) within the individual. (p 132) 
 
 SW3’s account here could be seen as an example of symptom-talk. His reference to 
“going over…symptoms” is formulated by SW1 as “the early warning signs” (30), 
which SW3 concedes. They are making reference to a recognised approach to 
working with “schizophrenia” presented by Birchwood, Spencer and Govern (2000) 
known as the “early warning signs approach to relapse prevention”17.  “Early warning 
signs” or “relapse prevention” was made reference to several times in the groups. 
We can see that referencing a recognised “approach” serves to add credibility to 
SW3’s account. SW3 suggests that he would make a case to Mark that if he does stop 
his medication “this could happen” (39) “this” being a resurgence of the presumed 
underlying illness in the form of “symptoms”. In SW3’s account, Mark, the 
medication and the “symptoms” are all located agency: Mark in how or whether he 
takes medication; the medication in keeping the “symptoms” under control; and the 
“symptoms” as an active process lurking beneath the surface ready to re-emerge 
                                            
17 This is an interesting integration of medical and psychological models developed by Clinical Psychologists. The premise behind 
this approach is that there are “early signs” indicating a “relapse” is imminent which individuals can be trained to recognise. 
They can then employ psychological strategies to help reduce the “relapse” occurring. This is done in the context of the service-
user being on “maintenance medication” and further medication being initiated when “early warning signs” develop. 
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given the opportunity. The suggestion being that medication is the only way the 
“symptoms” can be controlled and Mark would be making an irrational decision if he 
did stop his medication. 
 
It could be argued that SW3’s proposed conversation with Mark is threatening, 
however SW3 formulates it as “a kindof subtle way of trying to persuade him” (42). 
This has echoes of the ‘manipulative’ and ‘deceptive’ strategies talked about by 
psychiatrists in Seale et al. (2006; Section 1.9.2).  The need for “subtlety” is alluded to 
elsewhere, for example, Nurse 3 remarks: “one of the wor- most disempowering 
things you can do is to try to make it sound like its forced” (59-60). Perhaps the 
implication being that we are forcing you but we need to make it seem as if you have 
a choice.  
 
In the example presented here, the accounts the participants have given of how they 
would talk to service-users about the possibility of stopping medication, have been 
weighted strongly in favour of continuing with medication with threats that likely 
consequences are relapse. In other accounts, hospitalisation, deterioration and 
dangerous behaviour were presented as likely consequences. There were instances 
in the psychologist group where there was allusion to a more ‘balanced’ discussion 
about medication, with reference to “pros and cons” as we can see in Extract 18.  
 
Extract 18: Psychologists 
303. P3: I think yeah, I think it should be to have those kind of discussions  
about pros and cons in the context of like relapse prevention work  
could be a useful part of the discussion. 
            
Although, again in this extract we can see reference to “relapse prevention” (302), 
which might weight the “pros and cons” discussion in favour of medication.  
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3.3.6.3. A question of ‘insight’? 
Harper (1999b) shows that failure of service-users to take medication can be 
constructed by professionals as being an effect of their illness in term of lack of 
‘insight’ and as such valid objections to medication can be “de-legitimised”. I also 
noted this as a repertoire available to be drawn on by participants in this study, 
which further undermined the notion of service-users being able to make a ‘choice’, 
as in Example 19.   
 
Extract 19: Psychiatrists 
590. MD1: *….+ I always work uh what I  
 believe is in the best interests of client you know, so I’m trying to  
 work under the clinical excellence, ((.h)) it mean that, this guy  
 needs probably two or three trials *…+ with  
594.  enough uh dose of, of the medication, ((.h))and I’ll have to do my  
  best to treat his err his case properly with the medication, until he  
  will take insight because there is a good uh, chance that he will  
  have insight when he will be symptoms free// 
598.  M: //Mm// 
MD1: //because, lack of insight is is one of the symptoms, so if he was he  
will he will improve insight by the medication, then we can  
increase adherence and compliance, you know? *….+  
602.  this client, in my opinion, needs to be, to be on the  
medication because after the trial of the medication, as I said under  
the condition of the appropriate lengths and and dosage, he can  
make a more inform and more valuable decision for himself,  
whether he would like to stay on medication or not// 
 
At the beginning we see the medical paternalism seen in previous extracts (“best 
interests of client”; 591). We also see reference to “clinical excellence” (592) which 
might be a shortened reference to NICE, which serves to add credibility. Prescribing 
medication is presented here as a process of trial and error, but with an optimism 
that it is possible to get it right: “two or three trials *…+ with enough uh dose of, of 
105 
 
the medication” (593-594). This obscures the evidence that a substantial proportion 
of individuals receive no benefit at all from antipsychotics (Bentall, 2009).  
 
MD1 constructs “lack of insight” as a “symptom” (599) which can be relieved by 
medication (600) which in turn will: 1) increase compliance (601) and 2) enable Mark 
to make an informed decision about continuing medication or not (605). This is a 
curious argument as increasing medication “compliance” and being able to decide to 
discontinue appear to be contradictory. MD1 manages this problematic contradiction 
by the temporal distance between the two claims and through using the disclaimer 
“in my opinion” (602). By finishing on the claim about informed decision, MD1 
portrays her approach as reasonable: she is trying to give Mark the opportunity to 
think through the options without the influence of the “symptoms” which impair his 
judgement. What is implied is that without medication Mark is symptomatic and thus 
cannot be held responsible for not taking medication and cannot make an informed 
choice, but once medication is taken the presumption is that this will work to allay 
“symptoms”, bring “insight” and hence he could be held responsible for not 
complying.  
 
3.3.7. Constructing ‘Risks’ to Service-Users 
Participants talked about various conflicting ‘risks’ which service-users might be 
exposed to, which I will examine here. 
    
3.3.7.1. Legitimising Vs Minimising the ‘Risks’ of Medication 
Participants talked about ‘risks’ associated with antipsychotic medication in a range 
of different ways which could serve different functions: ‘risks’ could be legitimised or 
minimised, and agency and responsibility for problems associated with medication 
could be located in different objects and subjects. It is worth noting that there was 





Problems with medication were most often constructed in terms of “side-effects”. 
Harper (1999) has problematised this term: side effects are actually direct effects of 
drugs, which are unintended. He argues that through the notion of the “side-effect”, 
certain drug effects are constructed as proper and intended and other drug effects 
minimised as unintended and wrong. He suggests that this can serve to objectify the 
phenomena thus denying the subjective experience of the service-user, and locate 
responsibility away from professionals through the claim that these are unintended 
effects. In this study, participants were able to talk about “side-effects” in particular 
ways which further served to minimise these unintended drug effects.  
 
Extract 20 Nurses:  
90.  N1: Cos that is  
  quite a low dose and [all] 
M:  [Mm] 
N1: antipsytot- antipsychotics and going to have side effects. (4) So,  
 94.  s’about finding out what’s, wh- [what he thinks]  
M:  [whats bothering him most?] 
N1: about it. Is it just side-effects cos other medication are also going to  
 have side-effects (xxx) um, if he’s not tolerating this then he’s going  
98.  to have problems with other medications as well 
 
In Extract 20 Nurse 1 (N1) is making reference to Mark. There are three points made 
in her account: 1) that antipsychotic side-effects are inevitable (91-93); 2) that Mark 
is not “tolerating” the medication (97); 3) that Mark’s lack of tolerance would mean 
he would have problems with other medications (98). The claim that side-effects are 
an inevitable consequence of all antipsychotics has several implications: it serves to 
generally minimise their (the side-effects) importance and legitimise their 
acceptability, it ‘lumps’ all side-effects together as one entity which suggests that all 
are equivalently risky or unpleasant, and it suggests that side-effects are something 
that service-users just have to put up with. N2’s suggestion that Mark is not 
“tolerating” the medication potentially contradicts her claim for the inevitability of 
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side-effects, as it suggests that it is something about Mark’s physiology which is 
causing him in particular to experience these effects: Mark’s body is thus to blame 
(and indirectly Mark), not the medication. The notion of tolerability could also be 
seen as a moral judgement which implies that Mark is too weak to cope with the 
medication or is exaggerating the negative effects. We can see here the flexibility of 
what might be termed “side-effect talk” which can be utilised to minimise or obscure 
the unintended effects of medication, deflect responsibility from medicine or the 
pharmaceutical industry and locate problems within the service-user. It can also 
warrant particular courses of action and impede others: N1’s suggestion that if Mark 
cannot “tolerate” this medication he will be unable to “tolerate” others, could imply 
that it may be better for him to stay on the drug he is on, which serves to undermine 
any concerns he has expressed. Alternatively it could imply that it might be best for 
him to come off the medication and for alternative interventions to be tried. None of 
the groups drew on a ‘there are viable alternatives to medication’ repertoire.  
 
There were additional discursive strategies which were employed which served to 
minimise ‘risks’ or adverse drug effects. One device used was contrast. Taking 
antipsychotics could be compared with taking other types of medication, for example 
Social Worker 3 comments:  “Normally I give some example of y’know if if I’m taking 
antibiotics, I don’t like taking them..” (199-200). Stevens and Harper (2007) found 
that a similar strategy was employed in professional accounts of ECT where ECT was 
rendered just another medical procedure thus minimising potential controversies 
over its use. We have seen that service-users do not necessarily construct 
antipsychotics as equivalent to other kinds of medication (Rogers et al., 1998).  
 
The language used to describe adverse drug effects could also serve to minimise 
them, for example “[not] very nice” (SW3; 206) and causing “problems” (SW2; 9) 
which could be compared with the more extreme “dangers of coming off 
medication” (SW2; 8). Furthermore, service-users could be accused of fabricating 
side-effects because they did not want to take medication as we see in Nurse 3’s (N3) 
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claim that “I have one now who’s and (he’s he) he’s effectively making up symptoms 
which he doesn’t have which can be measured like by the LUNSERS18” (113-115). Not 
only does this serve to undermine the validity of service-user concerns, we can see 
that N3 appears to be using the term “side-effect” and “symptom” interchangeably 
which serves to blur the lines of causation: the effects can be attributed to the 
‘illness’ rather than the medication.  
 
Finally, the validity of service-user concerns about the ‘risks’ of medication could be 
denied as we can see in Psychiatrist 2’s (MD2) explanation: “..we can explain to them 
that these antipsychotics are not, you know, making them dependant on them you 
know.  They are not very highly tranquillisers or anything like that” (304-306). MD2 
as a psychiatrist has the category entitlement to make such a claim and give it the 
appearance of being factual, which disguises the controversial or potentially 
misleading nature of such statements. For instance Healy (2005) discusses the 
controversies and semantics around the notion of ‘dependence’ in relation to 
antipsychotics which would question the factuality of MD2’s statement. Johnstone 
(2000) has suggested that doctors often fail to pass on to service-users known 
hazards of medications.   
      
3.3.7.1.2. Legitimising 
Participants appeared to make value judgements about side-effects with some 
afforded more legitimacy than others. Participants talked specifically about certain 
side-effects as being particularly concerning, these included sexual dysfunction (in 
men), weight-gain (in women) and what might be categorised as sedation (“they find 
that they can’t think clearly, they’re tired” N1; 377-378). I will take one of these 
examples to explore in more depth. In Extract 21 the group are discussing the 
problem of weight gain. 
 
                                            
18 LUNSERS is an acronym for Liverpool University Neuroleptic Side Effects Rating Scale (Day, Wood & Dewey, 1995). This is a 
commonly used self-report rating scale. 
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Extract 21: Social Workers   
729. OT:  //Mm. I always wonder actually as a practitioner whether if  
  somebody prescribed me an antipsychotic// 
SW2: //Yeah// 
OT:  whether I’d want to take it I mean// 
 733. SW3: //Mm// 
OT:   if some- if I put two stone on in weight by somebody [s- prescribe-]  
SW2: [Yeah] 
OT:  I’m *((.h)) not convinced I would] 
[…..+ 
 741. OT:   //[so] I have to work with within that as well um and listen to what  
  people have got to say when they// 
SW2: //Yeah//  
OT:  //when you’ve seen them come in ((.h)) well I’ve worked in  
745.  inpatient settings when they’ve come in as a very tiny size eight  
young lady, [going out]  
SW2:  [Yeah] 
OT:  as a size twelve to fourteen. 
749. SW1:  Mm. [And carry on taking on taking it as well isn’t it?+ 
OT:  *And how. And carry on taking it.+ And I just think ooh um y’know. I  
can understand why you would not want to take that [medication.] 
SW2:  [Yeah] 
753. SW1:  And wouldn’t you be angry// 
SW2:  //Yeah// 
SW1:  that you’d been prescribed the one or the two that were most  
typical to *put on weight. I mean I think that’s kindof pretty..  xxx+ 
757. OT:  [Absolutely, yeah, absolutely yeah] 
 
The Occupational Therapist (OT) begins with “I always wonder” (729) with respect to 
what she would do if she was prescribed an antipsychotic. She is constructing an 
account where what she is about to say is based on rational thought rather than 
emotion (Edwards, 1999). She continues to build a vivid, narrative description of 
what might happen as a consequence of taking antipsychotics by drawing on several 
rhetorical strategies. She makes the proposition if she were to “put on two stone in 
weight” (734) which uses quantification to build an authoritative factual account 
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(Potter & Wetherell, 1994) of the real risks of taking antipsychotics. Perhaps as a 
defence against counter-claims that this is an exaggeration, she creates a footing of 
personal experience “when you’ve seen them come in” (744) and goes on to describe 
actual cases. She uses extramatization (Potter, 1996) combined with quantification 
again in her description: “a very tiny size eight” (745) which is then contrasted with 
“a size twelve to fourteen” (748). OT thus builds a picture of the dramatic effects 
antipsychotics can have in terms of weight gain, which is used as an explanation for 
her assertion that she would be reticent to take such medications herself (“I’m not 
convinced”; 736). On another level, what OT is doing here is constructing herself as a 
thoughtful and compassionate practitioner who takes the risks associated with 
antipsychotics seriously and can imagine what it must be like for service-users who 
are prescribed them.  
 
We might imagine that OT’s dramatic description of the risks associated with 
antipsychotics might lead her to go on to question their use, as to not do so would 
perhaps leave her open to the challenge that she is complicit in questionable 
practices. However, the conversation then takes an interesting turn when Social 
Worker 1 (SW1) joins in, which helps OT manage this predicament. SW1 takes up the 
conversation with “And carry on taking on taking it as well” (749), which OT then 
assents to (750). There is a suggestion here that the service-user should refuse to 
take the medication and by continuing to take it are to blame for the effects. The 
responsibility for the effects are thus located with the service-user not the 
professionals or the medication. However, as SW1 continues, it appears that some 
responsibility is located with psychiatry: “And wouldn’t you be angry… that you’d 
been prescribed” (753-755); but the medication (and OT) is let off the hook with the 
suggestion that these problems are particular to specific drugs: “you’d been 
prescribed the one or the two that were most typical to put on weight” (755-756), 
which suggests that a simple switch would solve the problem. Again we can see here 
an optimistic portrayal of medication: it is possible to find the right drug; an 




3.3.7.2. The ‘risks’ of psychosis 
Participants were able to draw on repertoires and devices which served to construct 
psychosis itself as being harmful to service-users.  
  
One such repertoire available was the ‘Untreated’ Psychosis is Harmful Repertoire, as 
demonstrated by Psychologist 3: “the message I’ve received about untreated 
psychosis and how damaging that can be” (182-183). This repertoire could be 
situated by participants in research and was a resource which could be drawn on to 
warrant the early use of antipsychotics as we see in Extract 22. 
 
Extract 22: Social Workers 
   249.  SW1: Mm. I think that that something else you can think about is that the  
early intervention in psychosis international guidelines from the  
research are to treat with a low dose of antipsychotic quickly to  
stop kindof brain damage// 
253. OT:  //Mm// 
SW1: //kindof happening and that that is the ethos of our team// 
SW3: //Mm// 
 OT:  //stop the extra cognitive dysfunctioning// 
257. SW1: //yeah, [yeah and]  
OT:  [as a] result of the illness// 
 
SW1 draws on the notion of “international guidelines” (250) which strengthens the 
credibility of the claim that not medicating can lead to “brain damage” (252). 
Although the claim is hedged somewhat with “kindof” (252;254) which allows SW1 
some flexibility if she hasn’t got the terminology quite right. SW1’s account 
constructs a sense of urgency with the addition of the temporal dimension of 
“quickly”. OT backs up SW1’s claim, suggesting that antipsychotics can “stop the 
extra cognitive dysfunctioning” (256) caused by “the illness” (258). Again we can see 
a disease process being constructed here which can be effectively stopped by 
antipsychotics. The strength of this argument is in its simplicity: who wouldn’t agree 
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that a pill which can stop “brain damage” should be used as quickly as possible? We 
can also see that comparing the consequences of not taking medication (“brain 
damage”) against the previously identified adverse consequences of taking it (weight 
gain, sexual dysfunction, sedation) weights the argument in favour of taking it.   
 
A similar argument is constructed through drawing on a repertoire which might be 
termed Psychosis is distressing. This repertoire constructs the experience of 
psychosis as awful, intolerable and uncontrollable. The implication being that the 
only solution is medication. We can see an example of this in Extract 23. 
  
Extract 23: Social Workers 
944. SW1: I’ve got a young guy who’s in hospital at the  
moment, and he has had like constant voices from the moment he  
wakes up till the moment he goes to sleep, and apparently (well)  
he’s only just started to talk about it but he’s had it for three years,  
948. and they’re talking about wanting to rape him and break his legs  
and he can smell blood and semen// 
SW2:  //Mm// 
SW1:  and ((.h)) that’s so horrendous to try and comprehend, in fact I can’t  
952.  comprehend *what kind of living hell he’s+ 
 *….+ 
959.  OK there are risks with the medication and a-, but it feels like its  
worth trying that at the moment and certainly he’ s agreeable  
*….+ 
965.  if we, can help that change, with medication  
then I would be for that. 
 
SW1 is using narrative and vivid description to demonstrate the awfulness of the 
psychotic experience. Her use of a ‘real’ case adds to the strength of her claim. We 
can see in the narrative discursive strategies like those used by OT in Extract 21  such 
as extramatization (“constant voices from the moment he wakes up” 945-946)  
which are used to work up the claim being made. We also see the use of dramatic 
lexis such as “horrendous” and “living hell”. The account builds up to the conclusion 
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that whatever risks are associated with medication, they can’t compare to how awful 
the psychosis itself is and so are worth trying (959-960). Note here that SW1 
constructs the service-user here as consenting to ‘treatment’ (“certainly he’s 
agreeable”; 959) which is in contrast to a case such as ‘Mark’ who is not agreeable. 
As such the claim being made by SW1 is not particularly contentious. However we 
could imagine a similar account being extended to justify coercive ‘treatment’.   
 
3.4. SUMMARY 
In this section I have presented an analysis of the construction of ‘risk’ in relation to 
the notion of antipsychotic medication ‘refusal’ as it appeared in the focus groups. I 
have illustrated how the fine level details of the ‘talk’ served to construct accounts as 
being valid. I have also demonstrated how repertoires were drawn on to position 
professionals, service-users and medication in particular ways which could warrant 
or legitimise certain actions and obscure others. In the final chapter I will discuss the 





In this section I will examine the findings from the survey and focus groups in the 
context of wider discourses and literature. I will go on to evaluate the quality of the 
research and its limitations. I will conclude by discussing the findings in terms of the 
implications for different stakeholders. 
 
4.1. FINDINGS IN CONTEXT 
4.1.1. Survey 
Diverse positions were presented by survey participants in relation to medication 
refusal. It was generally presented as a common encounter in their practice: almost 
all reported to have had some experience of it in the past year. Medication 
discontinuation was presented as often following expression of refusal and, as with 
Mind’s research on “coming off” (Section 1.8.5.1), participants suggested that 
service-users often stopped medication against advice (60%). The most common 
reasons professionals gave for service-users not  wanting to continue were similar to 
results reported from research with service-users: adverse physical effects, sedation, 
feeling better and not wanting to rely on medication long-term (Read, 2005; Cooper 
et al., 2007).  
 
The most common actions the participants indicated that they would take in 
response to medication refusal were to explore the issue with the service-user, 
arrange an appointment with the psychiatrist and discuss the risks with the service-
user. A minority (32%) endorsed the item: “consider supporting the client to come 
off”. The psychiatrist was presented as being most influential in decision-making 
about medication refusal, just ahead of the client and care-coordinator. The 
psychiatrist appears to be constructed by colleagues as responsible for dealing with 
issues related to medication refusal. It is interesting therefore, that so few 
psychiatrists took part in the research. Johnstone (2000) has suggested that 
psychiatrists are used covertly by society as “police” for problems no one else want 
to deal with: perhaps colleagues are positioning them as such here. We saw that in 
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the focus groups, other professionals could position themselves in this way too, by 
drawing on a Duty to Society Repertoire (Section 3.3.5.4.) 
 
Participants were able to take an optimistic position in relation to supporting people 
to come off medication. A majority of participants reported that they had had 
experience of supporting people to come off medication, or supporting people 
without using medication. A substantial proportion of attempts to support service-
users to “come off” were presented as successful, thus challenging the pessimistic 
picture generally presented in the professional literature (Section 1.8). This contrasts 
with the reluctance of focus group participants to position themselves as actively 
supporting service-users without medication (e.g. Section 3.3.5.1).  
 
4.1.2. Focus Groups 
In my reading of the focus group discussions, the dominant construction of 
medication refusal which emerged centred around the notion of ‘risk’. In Section 
3.3.3, I mapped out the main features of what I have labelled ‘risk talk’. Participants 
drew on various linguistic resources to ‘work up’ particular claims about ‘risk’ and its 
relationship to their practice.  
 
I examined how the professionals’ accounts served to construct service-users as both 
‘risky’ and potentially at risk from disease processes and medication. Professionals 
positioned themselves as arbitrators of these competing ‘risks’, situated within a 
struggle between wider discourses of freedom and choice versus public protection 
and coercion. This has echoes of Seale et al.’s (2006) research with psychiatrists, 
where a tension was demonstrated between being “patient-centred” and sharing 
decisions about antipsychotic prescribing, and the need to judge service-users’ 
competence to make decisions about medication.  
 
I have shown in my analysis, that risk repertoires were powerfully tied up with 
biomedical, legal and medication-related repertoires, which could flexibly construct 
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subject positions for service-users. They could, for example, be positioned as passive 
recipients of pathological processes, dangerous and unable to make decisions, which 
could potentially warrant legally sanctioned or, what might be termed, ‘veiled’ (for 
example through ‘persuasive talk’: Section 3.3.6.2), coercive ‘treatment’ with 
antipsychotics to stop the pathological processes. Conversely service-users could be 
attributed with agency, able to make decisions about taking medication or not, or 
about other ‘health-related’ behaviours such as taking drugs and hence could be held 
morally responsible and to blame if ‘wrong’ choices were made (for example Section 
3.3.4.3).  
 
Similarly, professionals could position themselves with and without agency: as 
passive automatons following the policies, procedures and norms of the service or 
system, with the warrant to be held responsible if these were not followed (for 
example Section 3.3.5.4), or as active, autonomous practitioners making decisions 
(for example Section 3.3.5.2). A further position available for participants to draw on 
was an ‘absent’ position, as we saw in the psychologists group (Section 3.3.5.5). Thus 
responsibility and agency for decision-making could be handed to others. However, 
as Willig (1998) has argued: inaction is an action. In failing to take a position, one is 
positioning oneself as complicit in sustaining current practice.   
 
It is important to keep in mind the notion that speakers are themselves positioned by 
the discourses in which they are embedded, and that discursive acts are constrained 
by the particular conditions in which speakers are located (Harper, 1995; Parker, 
1992). Harper (1995) suggests that a discursive analysis should ask: what interests 
are being served by the concept of X in this situation? In order to broaden my 
analysis, it may be useful to examine what interests are being served by the notion of 





Beck (1992) has referred to the Risk Society. His thesis is that contemporary western 
societies are moving to a “late modern” period where ‘risks’ have emerged due to 
globalisation, urbanisation and industrialisation. The prevention and minimisation of 
these ‘risks’ has become a central concern in contemporary society. Individual 
responsibility has become attached to ‘risk’, such that people are seen to both cause 
risk and be responsible for risk minimization. Lupton (2006) has outlined how other 
sociological writers have drawn on the Foucauldian notion of governmentality in 
relation to risk. Here, it is proposed that neo-liberal societies depend on the popular 
notion of individual freedom and rights, where external governance becomes 
internal self-government. Within this framework, risk discourses are a major 
apparatus through which self-regulation and personal responsibility are propagated. 
As the number of risk discourses grows, so do the number of risk-avoiding practices 
which citizens are required to attend to: ignoring ‘risk warnings’ is subject to moral 
judgement or stigma. Rose (1999) has theorised that psychology is complicit in these 
processes through its focus on the objective measurement of ‘the individual’. Within 
a governmentality framework, power relations are at work in the way ‘risks’ are 
socially constructed. As Crowe and Carlye (2003) suggest, there is no fixed or 
inherent risk which is revealed through observation, rather meaning is attributed to 
some characteristics rather than others in the construction of a ‘risky’ individual. 
 
It is interesting to apply the governmentality framework to the present research. We 
have seen how repertoires of choice and freedom were drawn on by professionals 
(Section 3.3.6.1.) These could be seen as neo-liberal discourses serving to conceal the 
concerns of the state to control social deviance and risk. Professionals were able to 
draw on these repertoires to attribute responsibility to service-users for ‘health-
related’ behaviour (i.e. taking medication): failure to comply with ‘health’ advice 
could lead to moral judgement and coercive measures. In this respect professionals 
are acting as agents of the ‘neo-liberal’ state. Furthermore, we have seen how 
professionals are able to draw flexibly on biomedical, legal and medication-related 




Beck (1992) discusses the role of medicine in the Risk Society. The professionalisation 
of medicine in nineteenth century Europe took illness away from people, making it 
the jurisdiction of medicine, which had the power to define pathological conditions 
and develop “technology” to administer them without external scrutiny or 
governance. Beck argues that the professionalisation of medicine has created a 
reflexive market strategy where ‘medical progress’ continually defines new health 
risks, whilst at the same time producing new treatment innovations, which extends 
its arena of practice.  
 
Kutchins and Kirk (1999) have detailed how increasing numbers of everyday 
behaviours or problems are becoming conceptualised as indications of mental illness 
by psychiatry, for example, not sleeping indicates Major Depressive Disorder; 
worrying is Generalised Anxiety Disorder; shoplifting is Conduct Disorder. One result 
of the increasing numbers of diagnosable mental disorders are more and more 
potential markets for the pharmaceutical industry to target with chemical cures as 
Johnstone (2000) and Moncrief (2008) have suggested. These authors present a 
picture of the pharmaceutical industry and psychiatry colluding to change the 
definitions and boundaries of chemicals and illnesses, based on business interests 
rather than ‘scientific’ decisions. Johnstone suggests that new drugs go through 
typical cycles of an accidental discovery with initial proclamations of miraculous 
effects leading to a buzz of excitement. As time goes on they are eventually 
recognised as no better than the treatment they purported to replace. As I discussed 
in Section 1.7.1.4, the ‘atypical’ antipsychotics might exemplify this process. A further 
contributor to the power of the pharmaceutical industry, highlighted by Johnstone 
(2000), is the control it extends over the ‘scientific’ literature. She suggest that 
medical journals often: rely on funds from drug advertisements for survival, have 
individuals on their editorial boards who have drug-company affiliations and publish 
drug company sponsored ‘supplements’ which are subject to less rigorous peer 
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review. Furthermore, Healy (2001) argues that trial outcomes which do not support a 
company’s interests are frequently not reported.     
 
In this context, the dominant institutions of medicine and the pharmaceutical 
industry serve to determine what is known about ‘mental illness’, its ‘treatments’ 
and the ‘risks’ involved. Professionals within their daily practice might thus be seen 
as pawns of this process as they draw on this apparently ‘scientific’ knowledge in 
their roles as arbitrators of risk. For example despite their now recognised failings 
(e.g. NICE, 2009) we saw that psychiatrists in the focus groups were able to draw on 
a repertoire of ‘medical progress’, where “atypical antipsychotics” were presented as 
advanced formulations compared favourably to previous treatments (see Section 
3.3.5.2).  
 
Going back to my initial question as to whose interests the notion of ‘risk’ in mental 
health serves, we can see that government, medicine and the pharmaceutical 
industry might be such beneficiaries. 
 
 
4.2. CRITIQUING QUALITY AND LIMITATIONS 
In this section I will evaluate the research in terms of its quality and limitations and 
comment on how fruitful combining the two types of method has been. 
 
4.2.1. Survey 
I have stated that I have not used the questionnaire in the way it might be 
traditionally used, which is to obtain a ‘valid’ measure of clearly defined phenomena. 
Rather, informed by social constructionist thinking, I have conceptualised it as a way 
of inviting participants to present positions on a topic. In using a questionnaire to do 
this, I have placed constraints around the possible positions which can be taken by 
participants, thus possibly obscuring variability: a criticism which Potter and 
Wetherell (1987) direct at such a methodology. However, pragmatically, I found that 
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using the survey alongside the focus groups has facilitated a broader exploration of 
the topic from a broader range of professionals and enabled me to capture some of 
the variability in positions available in relation to the topic. Furthermore, having 
asked survey participants to quantify the frequency of encountering medication 
refusal, I am able to conclude that professionals present this as a common 
encounter, which warrants a call for further research to be undertaken on the issue.  
 
Specific limitations of the questionnaire which might be addressed if it were to be 
refined for further use, particularly within a realist framework, include perhaps for 
the matters of coming off medication and not wanting to initiate medication to be 
separated and examined separately. Also, I did not provide a definition of ‘success’ in 
terms of coming off medication, leaving it to participants to define: I see ‘success’ as 
being uniquely defined by a service-user within the context of their world. Other 
researchers might critique this (as did one participant) and wish to provide a 
constraining definition to allow comparison across different studies. 
 
In terms of representativeness of the survey, a sample of 74 participants in survey 
terms is small, and as a self-selecting sample it could be critiqued as inherently 
‘biased’. My aim was not for representativeness and generalisability in a traditional 
positivistic sense, rather I aimed for a diversity of accounts to be collected from 
professionals working in different contexts.  There was little representation by 
psychiatrists who, as the professional group with perhaps the most interest and 
power with regards to medication, might present particular positions in relation to 
this issue which have been missed. Furthermore, a disproportionate sample of 
participants were clinical psychologists, due to recruitment through a BPS special 
interest group. This may have increased the availability of success stories about 
coming off medication. However, as I have suggested in relation to the focus groups, 




4.2.2. Focus Groups 
I have outlined why focus groups were chosen as a means to collect professional 
accounts in relation to antipsychotic ‘medication refusal’ (Section 2.2.2.1). In practice 
I found this to be a fruitful means to evoke and examine such accounts. Using groups 
rather than individual interviews allowed an examination of how particular discursive 
acts were orientated to by other members of the group, which was helpful in 
analysing the meanings which were being created within the groups (Potter and 
Wetherell, 1987). Although, focus groups do not constitute “naturally occurring” talk, 
they can demonstrate the discursive resources available for professionals to draw on 
and one might speculate that these resources are available for professionals to draw 
on in discussions with professionals and service-users.   
 
It is important to reflect on my position as researcher and facilitator of groups and 
how I have contributed to the meanings which were constructed in the groups. 
Firstly, I constructed the vignette which was used as an initial focus for the groups 
and was focussed on the groups to varying degrees. This vignette is open to be 
examined and deconstructed in itself as one means of evaluating my influence on the 
groups. Secondly, participants may have anticipated that I take a particular position 
on the topic by virtue of my profession and this may have indirectly located 
participants in particular subject positions in relation to me and limited what might 
or might not be said. Thirdly, I may have directly positioned people through my 
contributions to the focus group discussions. I have tried to make this transparent in 
the extracts I have drawn on in my analysis.  
  
4.2.3. Discursive Analysis 
Potter & Wetherell (1987) have identified ways in which DA work can be evaluated, 
which the reader is able to apply to my analysis. The first is coherence: analytic claims 
should give coherence to a body of discourse and how it fits together, functions and 
accounts for exceptions. I have attempted to do this throughout my analysis, by 
drawing attention to discursive micro-features as well as broader patterns in the data 
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with reference to extracts as examples. Where there are exceptions I have 
demonstrated how these can be accounted for. The reader is thus able to judge my 
analysis and the claims I have made. A second criteria is fruitfulness: “the scope of an 
analytical scheme to make sense of new kinds of discourse and to generate novel 
explanations” (p171). The ‘risk talk’ I have presented and the devices and repertoires 
inherent in it may be useful in examining and illuminating analyses of talk in other 
settings, for instance general medical settings or professional settings where ‘risk’ is 
a feature.  
 
A further criteria presented by Woods and Kroger (2000) is plausibility, by which they 
mean whether a set of claims is acceptable and makes sense in relation to existing 
‘knowns’, including existing literature. The reader is invited to judge the plausibility 
of my claims through their knowledge about social life and through comparisons I 
have drawn between my claims and other literature. 
   
4.3. APPLICATION 
4.3.1. Applying Discursive Research 
Harper (1995) has drawn attention to the problem of the straightforward application 
of DA research to practice: there are a variety of stakeholders with different stories 
to be told, however some are more dominant and powerful than others and the 
decision about which to privilege is political. Harper (1999a) draws on the concept of 
“usefulness” rather than application, in terms of whether suggestions lead to just 
and socially responsible outcomes. He has done this in his own research by focusing 
on specific stakeholders and suggesting the ways in which the research might be 
useful to them. This seems like a useful way to frame “applications” from this 
research. In doing this, in line with the critical stance I have taken in undertaking the 
research, I will privilege the concerns of service-users. Some suggestions I make 
might be liable for criticism as idealistic and it is likely that significant changes will be 
resisted by the powerful structures which hold mental health systems in place. 
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However small changes might snow-ball to make bigger changes to improve the 
experiences of service-users.  
 
4.3.2. Service-users 
Research findings might be most usefully disseminated to service-users through user 
newsletters, meetings and conferences.  
 
We have seen how professionals are able to draw on complex discursive resources 
when talking about medication, and may use techniques of persuasion with respect 
to medication refusal. Service-users could be made aware that the arguments 
professionals might make in this respect, for example about risks of relapse and of 
“brain damage”, are particular versions and that there are alternative accounts. 
Harper (1999a) suggests that training for service-users might facilitate this. Service-
users also need to be aware of their rights, in order that they might challenge 
practices such as veiled threats. Mind publish information leaflets about rights under 
mental health legislation which are available online for service-users to access. 
Awareness of government initiatives on “choice” and “involvement” may provide 
further leverage for service-users in obtaining the services to suit their needs. 
  
Service-users need to have access to independent advice about medications and how 
to safely come off them, as professionals may provide limited information. 
Questionnaire responses suggested that in some areas, groups were available for 
people who want to come off medication, where they can access support and 
information. Networks could be set up where service-users could support each other 
in this process, where those who had already been successful might mentor peers.    
 
4.3.3. Professionals & Academics 
Research findings might be most usefully disseminated to these parties through 
published literature and conference presentations. Also, participants of the research 
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were able to provide an email address if they wanted updates on the outcomes of 
the research. 
 
Professionals might be made more aware of the effects that particular ways of 
talking about medication refusal might have on relationships with service-users and 
that the use of ‘persuasion’ might contravene mental health legislation. They might 
become more aware that: critiques exist of the ‘truths’ about psychosis and 
antipsychotics; the risk of bias in research relating to medication; that the notion of 
‘risk’ is contested, not an absolute. Hearing about other professionals’ successes with 
supporting service-users to come off medication might empower more professionals 
to take such ‘risks’ themselves.   
 
Professionals may benefit from independent training about antipsychotic medication 
and coming off medication, in order that they might be able to provide the 
conditions for service-users to make truly informed choices. 
 
Professionals sympathetic to alternative approaches to psychosis might join with 
service-users in networks where expertise and knowledge might be shared and 
political pressure might be placed to challenge medical dominance. For example, 
professional groups were able to join with service-user groups in an alliance to 
challenge proposals to change mental health act legislation. The topic explored here 
is under-researched and professionals, academics and service-users might join forces 
to carry out more research. Charities such as Mind might be able to support further 
research in this area.   
 
4.3.4. Service Managers 
Managers of services could be made aware that the promotion of risk-averse 
repertoires constrains innovative and true user-focused service provision. As 
demonstrated by questionnaire respondents, drawing on NICE guidance (2009) can 
be used to justify the support of service-users in attempting to come off 
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antipsychotics. Service audits might be undertaken to measure the extent to which 
service-users are given this option and rates of success in order to build up “practice-
based evidence”. 
 
4.4. FURTHER RESEARCH 
Further research could analyse “naturally occurring” talk between professionals, and 
between professionals and service-users in relation to medication refusal, in order to 
identify whether the repertoires and devices which were demonstrated in this study 
are used in “real” conversations. Hepburn and Potter (2007) have undertaken 
discursive research on child abuse helpline telephone conversations. They have been 
able to provide staff with feedback and training, based on analyses of their 
conversations. A similar approach could be undertaken in relation to this topic. A 
further useful piece of research would be a detailed account of a professional and 





This research set out to examine professional perspectives on working with 
medication refusal in psychosis. It has shown that this is a commonly reported 
experience for professionals and that there are diverse accounts which can be 
provided by professionals in relation to the topic. In particular, professionals are able 
to draw upon flexible repertoires of risk to account for their actions in relation to 
medication refusal and warrant particular courses of action. These can be situated in 
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Appendix 1: Survey Questionnaire 
 





Information for participants 
 
Participation 
You are free to choose whether or not to participate in this research. By continuing to 
complete this questionnaire you are consenting to take part in the research project and the 
information you provide being subjected to analysis and publication. Your data will not be 
personally identifiable and will be kept confidential within the research team. You are free to 
withdraw at any time without any reason, simply exit the questionnaire and your data will 
not be saved. You are able to indicate whether you would like to receive information about 





Please follow the instructions for each question. You may work in different settings, however 
the questions relate to working with clients living in the community only. The situations of all 
the people we work with are very different, however when answering the questions please 












N.B. The questionnaire will be predominantly administered online, filters will be applied so that 
persons attempting to participate who do not reach the inclusion criteria will not progress to  






1. About you 
 
The following information is required to make sure you are eligible to participate and so that we 
have an idea of the range of people participating and their locations. You will not be asked to give 
your name. 
 
a) What type of team do you work in? 
 Community Mental Health Team  
 Early Intervention in Psychosis Team 
 Assertiveness Outreach Team 
 Crisis Intervention Team* 
 Community Forensic Team 
 Home Treatment Team* 
 Community Assessment Team* 
*Professionals working in these teams are not eligible to participate 
 





c) You must be a qualified professional to participate. What is your profession? 
 Psychiatrist* Please specify seniority ________________________________ 
 Clinical Psychologist 
 Counselling Psychologist 
 Mental Health Nurse 
 Social Worker 
 Occupational Therapist 
 Psychotherapist 
 Other: Please Specify _____________________________________ 
 
 
d) How many hours a week do you contribute to the team? 
_______________________________________________________________________ 
 
e) How many years post-qualification experience do you have? 
 0 – 2 years 
 2 – 5 years 
 6 – 10 years 
 11 – 15 years 
 15 – 20 years 
 20+ years 
 
f) How many years have you worked in a mental health team in the community? 
 0 – 2 years 
 2 – 5 years 
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 6 – 10 years 
 11 – 15 years 
 15 – 20 years 
 20+ years 
 
2. Role in the Team 
The next questions are to give us an idea of the work you usually undertake in your team. 
 
a) What are the main roles you play in the team? (Please tick all that apply) 
 Care Coordinator. 
 Undertaking assessments 
 Prescribing Medication. 
 Providing consultation to the team. 
 Administering Medication. 
 Monitoring Medication. 
 Managing social affairs, e.g. accommodation, benefits etc. 
 Providing short-term individual psychological interventions (1-10 sessions). 
 Providing longer term individual psychological therapy to clients (more than 10 sessions). 
 Running groups, e.g. anxiety management, relaxation etc. 
 Developing Programmes to support clients in developing daily living skills. 
 Managing the team. 
 Acting as an Approved Practitioner. 
 Care Manager. 
 Undertaking risk assessments. 




b) How many clients do you have on your caseload in the community team? 
______________________________________________ 
 





d) How many clients on your caseload are subject to Community Treatment Orders? 
 
________________________________________           Don’t know 
 
 
e) Do you have a special interest in issues relating to antipsychotic medication, medication 
withdrawal or non-medical approaches to psychosis? 
 
 No 






3. Clients on anti-psychotics 
The next questions specifically relate to working with people prescribed antipsychotic drugs. 
 
 
a) Approximately how many clients on your caseload in the community are currently 
prescribed an antipsychotic drug/s? 
___________________________________         Don’t know 
b) Approximately how many clients on your caseload currently (within the past month) have 




I. Approximately how many clients have you worked with in the past year who have expressed 
at some point that they wish to stop taking their antipsychotic drug/s? 
___________________________________________ 
 
II. Of these approximately how many have begun a process of discontinuing antipsychotic drugs 
with the support of services? 
_______________________________     Don’t know 
 
III. Of these approximately how many have stopped taking their medication against the team’s 
advice? 
___________________________   Don’t know  
 
d) In your experience, what are the most common reasons people give for wishing to 
discontinue or not initiate antipsychotic medication? 
 Adverse effects such as restlessness, un-controllable movements, weight gain, impotence 
etc.   
 Not wanting to rely on medication long-term. 
 Concerns about long-term health risks. 
 Medication not working. 
 Feeling worse on medication. 
 Not wanting the stigma of taking medication. 
 Wanting to try alternatives to medication. 
 Not feeling like myself or feeling too sedated. 
 Feeling the medication is poisoning them. 
 I haven’t discussed this with my clients. 
 Feeling better/cured 
 Other reasons: Please Specify 
 
e) When a client you are working with expresses a wish to discontinue antipsychotic 
medication, which of the following actions would you be most likely to take? 
 
 Try to persuade the client of the benefits of continuing to take their medication. 
 Discuss the matter with my team. 
 Discuss with the client the adverse consequences of this, in terms of the risk of admission to 
hospital. 
 Arrange or encourage the client to have an appointment with the psychiatrist. 
 Explore why the client wants to stop. 
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 Consider reducing or switching the client onto a different medication. 
 Discuss with the client the potential risks of stopping medication. 
 Discuss with the client the potential benefits of stopping medication. 
 Provide the client with written information about stopping medication. 
 Discuss alternatives to medication with the client. 
 Consider supporting the client to come off medication. 
 Undertake a risk assessment. 





I. Indicate who would usually be involved in decision-making about what to do when a client 
expresses that they wish to stop taking or not commence an anti-psychotic drug?  
II. Of those selected, please rate how much influence you think each has on the decision (1 = 


















































































































































 Don’t know. 
 
 


























I. Approximately how many clients in the last two years have you supported to successfully stop 













h) Please rate how confident you feel in supporting clients to discontinue antipsychotic drugs (1 = 
































i) What do you think would help you to feel more confident in supporting clients to discontinue 
antipsychotic drugs or manage psychotic experiences without drugs ?  
 
 Greater support from my team. 
 Access to research evidence of most effective ways to do this. 
 Specific guidance from a body such as NICE. 
 Access to alternative interventions to support client. 
 Resources to allow me more time to devote to supporting clients in this situation. 
 More training on this subject. 
 More research evidence that clients are able to successfully able to manage without 
medication. 




    
 
j)  
I. What non-medical approaches or support services do you provide/are available locally for 






II. What non-medical services/approaches/extra resources do you think would be helpful for your 







4. The research 
 
 
a) Would you like to receive further information about the research as it progresses? 
 
 No            




b) Would you be interested in contributing to the next stage of the research, which aims to explore 









How far would you be prepared to travel to take part in the next stage of the research? 
 
 I could only take part if it was in my workplace or very near by. 
 To the University of Hertfordshire in Hatfield. 
 I am not restricted to how far I would travel. 
 Other ____________________________________________________ 
_____________________________________________________ 
 

















Mark is a young man living with his mother and younger brother.  He has been involved with 
mental health services for several years and is currently prescribed Risperidone 2mg once 
daily.  
 
After leaving school he began an apprenticeship as a plumber. Several months later, his 
family started to notice that he was becoming more withdrawn and neglectful of himself. He 
started spending more time alone in his room on his computer instead of attending work 
and socializing with his friends. He became increasingly unable to meet his work and college 
obligations and eventually dropped out. He lost touch with most of his friends and became 
anxious about going out in the local area. He would often not respond to his family’s 
attempts to talk to him. At times he could be heard laughing and talking to himself in his 
room and could be verbally aggressive towards his mother and brother when asked about 
this. On one occasion he grabbed a knife from the kitchen and threatened to cut his wrists. 
When his mother had opportunity to enter his room, she always found the curtains closed 
and she could often hear that Mark was still up in the early hours of the morning.  
 
After coming to the attention of services, Mark was assessed and given a diagnosis of 
Paranoid Schizophrenia. He was reluctant to talk to professionals and always appeared 
anxious and suspicious when brought to appointments. On one occasion he said that they 
had been followed to the appointment and were being watched, but denied hearing voices. 
Mark was initially prescribed Olanzapine, 5mg once daily, which he took for several months. 
His mother noted that he was less aggressive and more likely to talk to her and his brother, 
but was still withdrawn and suspicious. Mark complained to his mother that he felt restless 
and was putting on weight. He started to refuse to take his medication and became even 
more withdrawn, telling his mother that the family were not safe and insisting that 
additional locks were put on the front and back doors. His mother became increasingly 
worried about him and was not sure how to manage his refusal to take his medication. Mark 
was visited at home by his psychiatrist, who told him that he was worried about him not 
taking his medication and discussed whether he might feel safer in hospital. Mark insisted he 
did not need to go to hospital and agreed to try a different drug. He was prescribed 
Risperidone, 2mg once daily. 
  
You have been working with Mark for several months and during this time on several 
occasions he tells you clearly that he does not want to take the medication. He tells you it 
makes him feel like he is separate from the world and that he always feels sleepy. He tells 
you he doesn’t like taking medication and that his father has told him it can cause health 
problems. At your most recent appointment, he tells you he is going to stop taking it 




Focus Group Moderator Topic Guide 
 
 
1. Introductions and ground rules of session 
 
2. Reading Vignette 
 
3. Questions – to stimulate discussion and to be followed flexibly: 
 
a. How would you respond in this situation? 
 
b. What factors would you consider? Which are most important? 
 
c. Are you able to respond as you would ideally want to? What prevents or supports 
this? 
 
d. Do you think other members of your team would respond in the same way? How 
might they respond differently? 
 
e. Do you see your role as important in situations like this? Do others see your role as 
important? 
 
f. How often would you face this type of situation? 
 
g. Are there ways in which you think your practice could improve? What supports or 
inhibits this? 
 
h. How important are issues relating to antipsychotic medication management to 
your profession? 
 
i. How are individuals who are reluctant to take antipsychotic medication viewed? 





Appendix 3: Information sheet for focus group participation 
RESEARCH PARTICIPANT INFORMATION SHEET (Version 1) 
Study title:  
An exploration of community mental health professionals' perspectives on working with 
people with psychotic experiences who do not wish to take antipsychotics.  
 
Dear ……………………………………….., 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you.  
Please do ask us if there is anything which is not clear, or if you would like more information, 
and take time to decide whether you would like to participate or not. 
 
What is the purpose of the study? 
My name is Sally Westwood and I am a Trainee Clinical Psychologist at the University of 
Hertfordshire. I am conducting this research as part of my doctorate qualification in Clinical 
Psychology.  
My research will be looking at the experience of working with adult service-users with a 
history of psychotic experiences who do not wish to take or wish to come off antipsychotic 
medication. Research has looked at this from the perspective of service-users, however my 
research is taking the perspective of mental health professionals. I am interested in all 
professional disciplines working in community teams, whether they prescribe and monitor 
medication as part if their role or not. Very little previous research has been carried out in 
relation to this subject and thus your contribution would be highly valued. It is hoped that 
the results will allow greater understanding of how professionals and services respond to 
this issue and changes which might need to be made to better meet the needs of 
professionals and service-users. The research will be submitted for publication when 
complete. 
  
In order to gain an understanding of this issues, I am looking to recruit five to six 
psychiatrists, community mental health nurses, social workers and  allied health 
professionals (occupational therapists, clinical and counselling psychologists, 
psychotherapists) working in mental health teams in the community to take part in uni-
professional focus groups.  
 
Why have I been invited? 
 You are from a professional discipline which the research is interested in.  
 You work in a community team with people with psychosis prescribed 
antipsychotics. 




Do I have to take part? 
It is wholly your choice as to whether you decide to participate or not. If you do decide to 
participate you will be given a copy of this information sheet to keep and you will be asked 
to sign a form recording your consent.  
 If you do decide to take part you are still free to withdraw at any time and without giving a 
reason.  
 
What will happen if I take part?  
To participate, you would be asked to take part in one tape-recorded focus group session 
lasting approximately 1 - 1½  hours. The setting is to be negotiated depending on who agrees 
to take part and may take place at the University of Hertfordshire or on NHS premises closer 
to where you are located. A fictitious case example will be presented at the session and you 
will be expected to discuss your response to this and issues surrounding the topic with peers 
from the same or a similar professional background to yourself. The resulting data collected 
will then be subjected to analysis. 
 
If you consent, you may be contacted at a later date to ask if you wish to comment on our 
research findings. You are able to decline this offer without giving a reason.  
 
What are the possible disadvantages of taking part? 
Participating in the study will place a burden on your time. However, it is anticipated that 
this will not exceed two and a half hours including travel time.   
Although topics to be discussed are not potentially distressing, reflection on your work in the 
focus group may cause you to consider different ways you could have understood a service 
user's difficulties or worked with a service-user. This may be a useful process, but might also 
evoke negative emotions. If any of the questions are experienced as being particularly 
sensitive, you do not have to answer them.    
 
What are the possible benefits of taking part? 
We can not promise that the study will help you. However, taking part will allow you to have 
time and space to reflect on your experiences and practice with peers. This process may 
allow sharing of good practice, and reassurance that others are faced with similar dilemmas.  
The topic being explored is currently under-researched and it is intended that this research 
will be published in professional journals. As such it may help other professionals to reflect 
on their own practice and contribute to an understanding of how services or organisations 
respond to the issues and might need to change in order to better address the needs of 
service users and professionals.  
 
What if there is a problem? 
If you have concerns about any aspect of this study you should ask to speak to the researcher 
who will do her best to answer your questions (Telephone numbers: 07957 638954, 01992 
313658). If you remain unhappy and wish to complain formally you can do so by contacting the 
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researcher’s Academic Supervisor at the university, Dr Alex Harbourne (Telephone number: 
01707 289449).  
Will my taking part in the study be kept confidential? 
All information collected about you throughout the course of research will be kept strictly 
confidential. Your name and other identifying information will be kept securely and 
separately from your tape-recording and the subsequent data-analysis. Your employer will 
not have access to any raw research data which may be able to identify you at any time. 
Due to the time constraints on this project an approved transcription service may be used to 
transcribe your interview. In this case your recording will be labelled A, B, C etc. to protect 
identity. The service will sign a non-disclosure, confidentiality agreement. 
Some parts of the data collected by this research will be looked at by authorised persons 
from the University of Hertfordshire (Sponsoring organisation) and the research team. 
Anonymised sections of the data collected may also be looked at by representatives from 
academic and professional assessment bodies in order to assess the quality of this doctoral 
research project. All will have a duty of confidentiality to you as a research participant. 
Your recordings and any identifiable data relating to your participation will be kept for up to 
5 years post research project submission (June 2015) according to the University of 
Hertfordshire’s ‘Good practice in research’ guidelines. All identifiable data will be destroyed 
by the chief researcher after this time in accordance with university guidelines. 
 
Are their any reasons where confidentiality may be breached? 
Due to your professional status, you will be regulated by a professional body. The researcher 
is bound by the British Psychological Society code of conduct and as such this will be 
followed with regards confidentiality: 
1. If you disclose information during the interview which leads to sufficient concern about 
your safety or the safety of others it may be judged necessary to inform an appropriate 
third party without formal consent. 
2. Prior to this occurrence the researcher’s project supervisor will be contacted to discuss 
any possible concerns, unless the delay would involve a significant risk to life or health.  
 
What will happen to the results of this research study? 
The results will be written up in the form of a thesis for the purposes of gaining a Doctoral 
qualification in Clinical Psychology. This will be publically accessible. 
I may ask you if you would like to comment on the analysis of the focus group to help with 
the accuracy of the results. You can decline your involvement. 
It is planned that the findings will be shared via academic publication and/or presentations. 
Participants will not be identified in any report or publication. Any quotes used will be fully 
anonymised. You have the right to decline the use of your quotes. 
 
Who has reviewed the study? 
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All research in the NHS is looked at by an independent group of people called a Research 
Ethics Committee to protect your safety, rights, dignity and well-being. This study has been 
reviewed and given a favourable opinion by the Hertfordshire Research Ethics Committee 
who have raised no objections on ethical grounds. The research has also been reviewed and 
agreed by the research and development committee within your employing organisation 
Due to the academic nature of the research, this project has also been subjected to both a 
formal and a peer review by the University of Hertfordshire’s Doctoral Programme in Clinical 
Psychology. 
 
Further information and contact details 
Should you have any further questions or any concerns during the study please do not 
hesitate to contact the researcher or her research supervisor using the contact details 
provided below. 
If you are interested in potentially participating in this study please fill in the reply sheet 
included with this information sheet and return to Sally Westwood (Chief Investigator) via 
email. 
Should you wish to complain about this study the Independent Complaints Advocacy Service 
(ICAS) supports individuals wishing to pursue a complaint about the NHS. 
(http://www.dh.gov.uk/en/Managingyourorganisation/Legalandcontractual/Complaintspolic
y/NHScomplaintsprocedure/DH_4087428) 
   




Ms Sally Westwood    Dr Alex Harborne   
  
Chief Investigator   Academic Supervisor 
Trainee Clinical Psychologist    Clinical Psychologist & Research Tutor 
University of Hertfordshire.   University of Hertfordshire 
s.j.westwood@herts.ac.uk   a.harborne@herts.ac.uk 
07957 638954     01707 289449 
01992 313658 
       




Calling all mental 
health professionals 
working in community 
teams! 
 
Appendix 4: Research Advert  
Research 
 
Anti-psychotics: What happens 
if someone doesn’t want to take 
them? 
 
Can you help? 
As part of my Clinical Psychology doctorate 
at the University of Hertfordshire, I am 
undertaking some research into the  
experience of working with adult service-users with a history of psychotic experiences 
who do not wish to take or wish to come off antipsychotic medication.  
 
Research has looked at this from the perspective of service-users, however my research 
is taking the perspective of mental health professionals and I am interested in all 
professional disciplines working in community teams, whether they prescribe and 
monitor medication as part if their role or not. Very little previous research has been 
carried out in relation to this subject and thus your contribution would be highly valued. 
It is hoped that the results will allow greater understanding of how professionals and 
services respond to this issue and the research will be submitted for publication when 
complete. 
 
How can I take part? 
I have developed a short online questionnaire to collect information about your 
experience of this matter. It doesn’t matter how experienced you feel you are with this 
matter or not, I would like to hear from you. Please click on the following link to take 
part: [address]. It should not take you longer than approximately 20 minutes.  
 
The second part of the research will consist of focus groups or interviews with a small 
selection of professionals and you can indicate on the questionnaire whether you are 
interested in taking part in one of these too.   
 
What if I want to know more? 
Please email me at: s.j.westwood@herts.ac.uk if you would like further information, or 
feel you could contribute to helping with the research in other ways. 
 
Thank you for your time. 
 
Sally Westwood 
Trainee Clinical Psychologist 
Doctor of Clinical Psychology Training Course 
University of Hertfordshire  
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Appendix 5: Invitation to participate in focus group  
C/O Doctorate in Clinical Psychology course 












Re: Research Focus Group - An exploration of community mental health professionals' perspectives 
on working with people with psychotic experiences who do not wish to take antipsychotics.  
 
As part of my Clinical Psychology doctoral training, I am undertaking research into professionals’ 
experiences of working with service-users with a history of psychotic experiences who wish to 
“come off” or stop taking antipsychotic medication. Research has been undertaken relating to this 
topic from the perspective of service-users, however there is little research exploring the 
perspective of mental health professionals. I am interested in professionals working in community 
teams, whether or not they prescribe and monitor medication as part if their role. It is hoped that 
the results will allow greater understanding of how professionals and services respond to this issue 
and as well as being written up as a doctoral thesis, the research will be submitted for publication. 
 
You may have already taken part in the first stage of my research, which involved completing a 
questionnaire or you may have been contacted to help me by a member of your team. The second 
stage of the project involves taking part in a focus group discussion to explore the issues in more 
depth. This is what I would like your help with. I plan to hold four focus group discussions of 
different professional groups. The groups will be as follows: a group of psychiatrists, of community 
mental health nurses, of social workers and of allied health professionals (i.e. occupational 
therapists, psychologists, psychotherapists). I hope to recruit approximately  5-6 professionals to 
take part in each session.  
 
To participate, you would be asked to take part in one audio-recorded focus group session lasting 
approx. 1 - 1½  hours. The setting is to be negotiated depending on who agrees to take part and 
may take place at the University of Hertfordshire or on NHS premises closer to where you are 
located. A fictitious case example will be presented at the session and you will be expected to 
discuss your response to this and issues surrounding the topic with peers from the same or a 
similar professional background to yourself. The resulting data collected will then be subjected to 
qualitative analysis. 
 
If you are willing to consider participation or would like more information, please contact me using 
the details at the top of the letter.  Thank you in advance for your time. I look forward to hearing 






Ms Sally Westwood      Supervisor: Dr Alex Harborne 
Chief Investigator      Clinical Psychologist & Research Tutor 
Trainee Clinical Psychologist      University of Hertfordshire 
University of Hertfordshire.     a.harborne@herts.ac.uk   




 Reply Sheet 
 








2.  I may be interested in participating in this project but would like further 
information.  
  




3.  I am interested in participating in this project.  
 



















If telephone, suitable times for contact (E.G. Mondays 12-2pm): 
Day:     Times: 
Day:     Times: 
Day:     Times: 
 




Appendix 6: Focus Group Consent Form 
 
RESEARCH PARTICIPANT CONSENT FORM (Version 1) 
 
Title of Project: An exploration of community mental health professionals' perspectives on working with 
people with psychotic experiences who do not wish to take antipsychotics.  
Centre number: 
Study Number: 
Participant identification number: 
Name of researcher: Sally Westwood, Trainee Clinical Psychologist. 
To be completed by participant (Please initial each box): 
 Initials 
1. I confirm that I have read and understand the information sheet date 15
th
 July 2009 
(Version: 1) for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily.   
 
2. I understand that I am free to decline entry into the study and I am able to leave the study 
at any time without reason?  
 
3. I consent to the tape recording of my interview  
4. I understand that relevant sections of the data collected by this research will be looked at 
by authorised persons from the University of Hertfordshire (Sponsoring organisation) and 
within the research team. Anonymised sections of the data collected may also be looked 
at by representatives from academic and professional assessment bodies in order to 
assess the quality of this doctoral research project. All will have a duty of confidentiality to 
me as a research participant 
 
5. I agree to take part in the above study.  
6. I agree to be contacted for my comments on the findings of the study. I am aware I can 
decline my involvement at any time. 
 
7. I agree that anonymised quotes from my interview may be used in any publications.   
8. I would like to receive a summary of the results from the study: 
 Yes              No 
 
 
Participant Signature: ___________________________________________ Date: ______________  
Name: ______________________________________________ 
 





















Appendix 10: Information on survey participants’ responses in relation to the question: 
Do you have a special interest in issues relating to antipsychotic medication, medication withdrawal or non-medical approaches to psychosis (If Yes 













Assertive Outreach clients are largely non-compliant with their prescribed medication, and therefore non-medical 
approaches are ofetn key to engagement and recovery 
5 
Mental Health Nurse 
EIPS 




only during training 
11 










holistic, non-medical approaches, particularly meaningful activity. Also the importance of socail skills training in helping 
people experiencing psychosis 
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First episode psychosis, at risk mental states for psychosis and psychological approaches to psychosis are all special 
interests. 
20 
Mental Health Nurse 
CMHT 
Medication management  Weight management   Healthy eating 
21 
Mental Health Nurse 
EIPS 
non-medical approaches to psychosis especially during crisis / acute presentations.  reducing and coming off psychiatric 




Individual or group support and written information to support medication withdrawal 
24 
Mental Health Nurse 
EIPS 
cbt, assisting clients to reduce or come off medication after a two year period if symptom free and after discussion with 
client and family 
25 
Mental Health Nurse 
EIPS 




I'm interested in antipsychotic medication and non-medical approaches in mild psychosis (that is below the threshold for 
a diagnosis of a psychotic illness) 
27 
Mental Health Nurse 
AOT 
Solution Foused Brief Therapy    Mindfulness based approaches to strees reduction 
166 
 





as a clinician who deals everyday with patients taking antipsychotic medications it is absolutely pivotal a clear and deep 
understanding of every issue related to the compliance in this field. as a psychotherapist I am also very interested in 
understanding the role that antipsychotic medications have in keeping the patient within boundaries approachable to a 
psychotherapeutic interventios. and last but not least I am really interested in gaining a deeper knowledge about the 




psychological approaches to understanding and coping with psychosis 
31 
Clinical Psychologist 
Community Forensic Team 
CBT for psychosis, Hearing Voices approaches to working with voices, safe medication withdrawal and management of 










Psychological and alternative approaches to working with people suffering from psychosis 
35 
Clinical Psychologist  
EIPS 
Non medication approaches Inc psychological therapy and understanding person's own view of difficulties and options 
for facilitating recovery 
36 
Clinical Psychologist  
EIPS 
Concerns about the contribution of medication to 'classical' presentation of longer term psychiatry clients ('SMI' group) 
and if iatrogenic.  Concerns about effects of neuroleptics on medication-naive brains of young people with first episode 
psychosis  Terminology such as medication 'compliance'  Perpetuation of the medical model 
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Non-medical approaches to psychosis - psychodynamic and cognitive perspectives 
47 
Clinical Psychologist  
EIPS 
i thin it'd be interested to conduct RCT in which one of the branches is 'not onlong term antipsychotic medication' + alos 
interested in the potential role of alternative medication that have less SE e.g. antidepressant, anxiolytic 
48 
Clinical Psychologist  
EIPS 
non-medical approaches to psychosis - psychological therapies 
49 
Mental Health Nurse 
CMHT 
Looking more into the non-medical approaches 
50 
Social Worker  
AOT 




Social Worker  
CMHT 
Trained in Psycho-social interventions for psychosis (including CBT, family interventions etc) 
52 
Mental Health Nurse 
EIPS 




efficacy, side effects 
55 
Clinical Psychologist  
EIPS 












I am interested in learning more about living with pschosis but without medication 
62 
Mental Health Nurse 
CMHT 
All depending on the individual 
63 
Clinical Psychologist  
CMHT 
Previously conducted doctoral reseach on cognition in psychosis.  Also worked on research projects investigating 
psychological therapies for psychosis including group CBT for voices, Cognitive Remediation, and Motivational 
Interviewing for medication concordance in this client group.   During training undertook specialist placements in 










all of the above 
69 




Mental Health Nurse 
EIPS 





Talking therapy allowing the patient to talk about the experience of being psychotic and exploring with them what they 
find helpful to manage their symptoms.  Whilst medication helps some patients others do not find it helpful at all. 
74 






Non-medical approaches to psychosis - psychodynamic and cognitive perspectives 
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Appendix 11: ‘Other Reasons’ given by participants in response to question: 
“If a client you are working with expressed a wish to stop taking antipsychotic medication, which of the following actions would you be 









Think "persuade" is too strong a word in above question -would discuss the benefits. 
21 
Mental Health Nurse 
EIPS 
 
in addition to the three i have ticked as standard i would discuss alternative to medication, alternative medication choices 
(should the reason be side effects), explore why the client wants to stop, discuss the experience of others who coming off 
and provide written information on these, sign post to local group re. coming off medication, support the client to discuss 




would usually share with the client's care coordinator 
31 
Clinical Psychologist 
Community Forensic Team 
I'd discuss with them coach/practise a) alternative ways of dealing with the issues that the medication was meant to deal 
with, and b) plan how to manage withdrawal or rebound symptoms and encourage them to see stopping medication as a 




It will depend a lot on the client's history - so if it looks like the meds don't make much difference then I might 
recommend to my team we support them coming off.  If they have ended up in hospital each and every time they have 
stopped them - then I'd probably try to persuade them to keep taking them,  in either case I would think it appropriate fo 




I would discuss the pros and cons of stopping medication vs the pros and cons of continuing medication 
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Help the client think back about the context of being prescribed the medication to help develop a wider story about the 








Discuss with the psychiatrist and arrange an appointment with them so the patient can discuss with the doctor all the 




Appendix 12: ‘Other Reasons’ given by participants in response to question: 
“What do you think would help you to feel more confident in supporting clients to discontinue antipsychotic drugs or manage psychotic experiences 








Clinical Psychologist  
EIPS 
More experience within the team in the process of supporting clients to discontinue - it is only recently we have been 




The bigger issue of use of medication and role of Psychiatrists within CMHTs (teams) - highly dominant culture of medical 




It depends what you mean by feeling confident - I'm very happy to support clients to explore what they want and make 
choices about medication.  I'm not always confident it'll work out for them so there's a certain retiscence that seems 
appropriate to the risks of relapse. 
36 
Clinical Psychologist  
EIPS 








It depends on the client !  In practice it is very difficult to do without the support of the psychiatrist gruding or otherwise. 
55 
Clinical Psychologist  
EIPS 








I think that there is a sufficient body of evidence that most people will have to take medications. Discontinuing 
antipsychotics is more about finding out who is from this lucky minority (10-20% ) who can manage without medications. 
Most importantly, to make sure that those who do relapse cann acess help and medication asap when they need it again. 




Appendix 13: Breakdown of participants’ responses to the question: 
 
 
Of the people listed below, in your experience, indicate how much influence each USUALLY has on the decision-making when a client expresses that 
they wish to stop taking or not initiate antipsychotic medication. Rate each on a scale of 1 - 5 (1 = minimal influence, 5 = most influence) or tick the last 
column if that person would not USUALLY be involved in the decision-making.  
  answered question 68 
  skipped question 6 
  
1 = Minimal 
Influence 







The Client. 2.9% (2) 8.8% (6) 19.1% (13) 36.8% (25) 32.4% (22) 0.0% (0) 3.87 68 
The Care-Coordinator. 1.5% (1) 5.9% (4) 27.9% (19) 55.9% (38) 8.8% (6) 0.0% (0) 3.65 68 
The client’s 
Psychiatrist. 
1.5% (1) 1.5% (1) 13.2% (9) 35.3% (24) 47.1% (32) 1.5% (1) 4.27 68 
The Multi-Disciplinary 
Team. 
10.3% (7) 17.6% (12) 36.8% (25) 25.0% (17) 5.9% (4) 4.4% (3) 2.98 68 
The client’s 
partner/carers/family. 
4.4% (3) 38.2% (26) 33.8% (23) 20.6% (14) 2.9% (2) 0.0% (0) 2.79 68 
The Care Manager. 10.3% (7) 19.1% (13) 20.6% (14) 8.8% (6) 2.9% (2) 38.2% (26) 2.60 68 
The client’s 
Therapist/Psychologist. 
10.3% (7) 23.5% (16) 32.4% (22) 19.1% (13) 1.5% (1) 13.2% (9) 2.75 68 
An advocate for the 
client. 
13.2% (9) 17.6% (12) 26.5% (18) 8.8% (6) 1.5% (1) 32.4% (22) 2.52 68 
A second opinion 
doctor. 
16.2% (11) 10.3% (7) 11.8% (8) 11.8% (8) 8.8% (6) 41.2% (28) 2.78 68 
Staff at a client’s place 
of residence (e.g. 
hostel staff). 
13.2% (9) 29.4% (20) 25.0% (17) 11.8% (8) 1.5% (1) 19.1% (13) 2.49 68 
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2. Reasons for not taking meds 
3. Outcomes of stopping meds 
4. Coming off meds 
5. Insight 
6. Actions taken/Interventions by professionals 
7. Role of professional/s 
8. Service Context 
9. Professional anxiety 
10. Alternatives to medication 
11. Empowerment 
12. Mental Health Act and hospitalization 
13. Community work 





19. Decision-making about medication 
20. Working in Partnership/Choice 
 
Other Features  
1. Case anecdotes 
2. Talking from own experience 
3. Constructing the “client” 
4. Constructing “compliance” 
 
